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LIST OF ABBREVIATIONS 
 
Chemical reagents and solutions 
AA-BA   solution of 30% acrylamide / bis- acrylamide, mixing ratio 37.5:1 
APS   ammonium peroxydisulphate  
ATP   adenosine 3’ triphosphate 
BDM    2,3-butanedione monoxime 
BSA   bovine serum albumin 
Ca2+          calcium ion 
CaCl2   calcium chloride 
CO2   carbon dioxide 
Cy3     cyanine derived fluorochrome 
EGTA   ethylene glycol-bis(2-aminoethylether)-N,N,N′,N′-tetraacetic acid  
FITC     fluorescein isothiocyanate  
GA    glutaraldehyde 
H2O   water (distilled) 
HCl   hydrochloric acid 
KCl   potassium chloride 
KH2PO4    potassium phosphate monobasic  
K2HPO4    potassium phosphate dibasic  
KOH   potassium hydroxide 
MOPS    3-(N-Morpholino) propanesulfonic acid 
MgSO4   magnesium sulfate 
NaCl   sodium chloride  
NaHCO3  sodium bicarbonate  
Na2HPO4    sodium phosphate dibasic  
NaOH   sodium hydroxide 
NaN3  sodium azide  
NH4Cl  ammonium chloride  
PBS    phosphate buffered saline 
PBS-Tx  phosphate buffered saline /  0.1% triton x-100  
PFA    paraformaldehyde 
PFA-Tx   4% paraformaldehyde / 0.1% triton X-100 / PBS solution 
PI3K    phosphoinositol-3-kinase  
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SB   solubilization buffer 
SDS  sodium dodecyl sulfate 
TB   transfer buffer 
TBS  tris buffered saline  
TES      N-[Tris(hydroxymethyl)methyl]-2-aminoethanesulfonic acid 
TEMED  N,N,N',N'-Tetramethylethylenediamine, 1,2-Bis(dimethylamino)-ethane  
Tris   tris(hydroxymethyl)aminomethane 
Tx    triton X-100 
Measuring units 
°C   degrees Celsius  
h  hour 
kcal     kilocalorie  
kDa   kilodalton 
M  mol per liter 
mA  milliampere 
MDa    megadalton  
min   minute  
ml  milliliter 
mm   millimeter 
mM   millimolar, (millimol per liter) 
nm  nanometer 
s  second 
V  Volt 
v/v     volumetric ratio  
w/v  weight per volume ratio  
µg   microgram 
µl  microliter 
µM  micromolar 
µm   micrometer  
Physical constants and measures in equations and graphs 
A   persistence length  
d   diameter 
dpi   dots per inch 
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E     Young’s module ~7,7·1011mg/cm2   
f   force  
FWHM   full width at half maximum 
g  gravitational constant (9.81 m/s2) 
I  geometrical moment of inertia 
i    intensity of the electric current 
kB     Boltzmann constant  
L  contour length  
LVEDP  left ventricular end diastolic pressure 
MW     molecular weight  
OV     optical volume (measured by TotalLab software)  
pCa   negative decimal logarithm of molar Ca2+ concentration 
pH  negative decimal logarithm of molar H+ concentration 
Q    electrical charge 
SL   sarcomere length 
z     chain extension  
L  displacement of the emitting fiber’s tip 
L     length of the optical fiber  
V0   maximum unloaded velocity of sarcomere shortening 
ΔV    voltage, the electric potential difference between two measuring points 
Other abbreviations 
8I-7     a troponin I specific antibody 
BD6    titin specific antibody BD6 
CAD     coronary artery disease 
CCD     charge-coupled device  
COL1     a collagen I specific antibody, clone 1 
cTnI    cardiac troponin I  (also referred as c1, c2, d  bands on Western blot) 
DCM   dilated cardiomyopathy 
e.g.   exempli gratia (lat.), for example 
F     female 
FH-7A  a collagen III specific antibody 
FHC     familial hypertrophic cardiomyopathy  
FN-3   fibronectin type-III-like  
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HH(s)  human heart(s) 
i.e.    id est (lat.), that is 
IFM     indirect flight muscles  
Ig     immunoglobulin-like  
IgG  immunoglobulin G 
LAD     left anterior descending coronary artery 
LDA     length-dependent activation  
LV     left ventricle of the heart 
M    male 
MG1   MG1 antibody against titin 
MHC   myosin heavy chain  
MI    myocardial infarction 
MyBP-C   myosin-binding protein-C  
NYHA   New York Heart Association  
N2-A    N2-A titin domain 
N2B     titin isoform N2B or a specific segment of this isoform, when indicated  
N2BA    titin isoform N2BA 
N2BA-1  titin N2BA isoform of 3700 kDa  
N2BA-2   titin N2BA isoform of 3500-3600 kDa   
N2BA-3  titin N2BA isoform of 3200 kDa 
N2BA-4   titin N2BA isoform of 3400 kDa 
PEVK   PEVK domain of titin 
RV     right ventricle of the heart 
SS  Sommersemester (german) 
SDS-PAGE  sodium dodecyl sulfate polyacrylamide gel electrophoresis 
SEM   standard error of the mean 
T1   full length, intact titin bands on gels 
T2 or T3   the titin-degradation bands on gels 
TnI    troponin I  
uN2B    N2B-unique sequence 
USA   United States of America 
WLC   worm-like chain model of entropic polymer elasticity 
WS  Wintersemester (german)
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1. INTRODUCTION 
 
1.1 Muscle contraction and three-filament model of the sarcomere 
 
Already in the XIX century, striated muscle was known to produce active force during 
contraction. Also passive tension generation upon stretch was quantitatively described as a 
non-linear length-tension curve (Roy, 1881). The current concept for striated muscle 
contraction, the sliding filament theory, was proposed half a century ago (Huxley and 
Hanson, 1954; Huxley and Niedergerke, 1954). Accordingly, in the sarcomere, the structural 
unit of muscle, the interdigitating bundles of thick (myosin) and thin (actin) filaments slide 
past one another but do not change their actual length. The net result is a shortening or 
lengthening of the sarcomere. The muscle is hierarchically organized, in that serially linked 
sarcomeres form the myofibrils align parallel in the muscle fiber (myocyte). Many fibers 
build the fascicles (fiber bundles), which then form the whole muscle. Shortening of a whole 
muscle results from coordinated contraction of the individual fibers and the total shortening 
of a muscle fiber is close to the sum of the individual shortenings of the serially linked 
sarcomeres in the fiber. 
Muscle function can be grossly distinguished in two states: a) the active state or 
contraction, in which the muscle produces work on the basis of ATP consumption, and b) the 
passive state, in which the muscle is not activated, but can still produce “passive work” when 
stretched from its resting length. These states can be readily described experimentally by 
three main parameters: force, length (change), and time, from which other parameters can be 
inferred: shortening velocity, work, and power output. In skeletal muscles, the active 
(developed) tension is typically much higher (>10 times) than the passive tension at 
physiological sarcomere lengths (SLs), whereas in cardiac muscle the relative contribution of 
passive to total (passive + developed) tension is quite substantial (Linke et al., 1994). Active 
tension has long known to be generated by the cyclic interaction between myosin heads and 
actin filaments. Passive tension also originates to a large part in the sarcomeres, namely in the 
elastic filament system. The existence of such a "third intrasarcomeric filament" holding actin 
and myosin filaments together was first proposed when thin and/or thick filaments were 
experimentally dissolved but the sarcomeres did not disintegrate (see Funatsu et al., 1990 and 
references therein). Maruyama et al. (1977 a, b) and Wang et al. (1979) proposed that the 
third filament is made of connectin (later named titin) molecules. Earlier concepts for passive 
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muscle elasticity, which had suggested that only extrasarcomeric, particular extracellular, 
elements (collagen) may be responsible for passive tension generation, were re-evaluated and 
the mechanical role of titin filaments soon became more generally accepted. 
A step forward in the understanding of titin function was made when single titin 
molecules about one micrometer in size could be isolated from muscle and observed in the 
electron microscope (Figure 1) (Maruyama et al., 1984; Trinick et al., 1984; Wang et al., 
1984; Nave et al., 1989). Subsequently it was shown that titin molecules reach across one half 
of a sarcomere, with the molecule’s N-terminus anchored at the Z-disk and the C-terminus at 
the M-line. As the N-termini of titin from adjacent sarcomeres interact in the Z-disk and the 
C-termini of antiparallel titin molecules overlap in the M-line, a continuous filament system 
is formed in myofibrils. Titin may thus help center the thick filaments in the sarcomere.  
 
 
Figure 1. Electron micrograph of a single titin molecule purified from rabbit back muscle. 
The molecule is straightened by denaturant agents to ~1.3 μm length, which is close to the 
predicted length considering the primary structure (from Tskhovrebova et al., 2002). 
 
1.2 Molecular structure of titin - one gene, multiple isoforms 
 
Sequencing of the A-band part of human titin showed that this section of the molecule 
is composed of ~42-nm long super-repeats of immunoglobulin-like (Ig-) and fibronectin type-
III-like (FN-3-)domains (Figure 2), which regularly bind myosin tails and myosin-binding 
protein-C (MyBP-C) along the thick filament (Labeit et al., 1990, Fürst et al., 1989). Ig and 
FN3 sequence motifs result in ~4 nm diameter globular polypeptide modules (Trinick et al., 
1984; Whiting et al., 1989) with tertiary structure of 7 or 8 antiparallel beta sheets (Leahy et 
al., 1992; Pfuhl and Pastore, 1995; Politou et al., 1995). The structure of A-band titin is 
highly conserved among mammalian muscles. The A-band titin region binds not only myosin 
and MyBP-C, but also associates near the M-line region with a number of other ligands 
(Figure 2), such as the M-line proteins, myomesin and M-protein (Obermann et al. 1995; 
1996; 1997; van der Ven and Fürst, 1997). There is a kinase domain near the M-line titin 
(Figure 2) which is involved in protein-protein-interactions and myocyte signalling (reviewed 
by Trinick and Tskhovrebova, 1999; Gregorio et al, 1999; Clark et al. 2002). 
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Figure 2. A-band titin structure. Super repeats composed of Ig and FN-3 domains have
A-band titin possibly is a template upon which other proteins are arranged during 
sarcom
and Kolmerer, 1995) was 
final pr
 
regular sites binding myosin tail and thick filament associated C-protein (MyBPC). Various 
titin ligands were identified by in vitro studies with antibodies, recombinant titin fragments 
and yeast two-hybrid systems (modified from Gregorio et al., 1999). 
 
erogenesis (Whiting et al., 1989). For instance, A-band titin may determine the precise 
assembly of thick filaments, because the periodicity of its super-repeat pattern matches that of 
the myosin heads (reviewed by Trinick and Tskhovrebova, 1999).  
Publication of the full-length human titin sequence (Labeit 
oof for the proposal that a single polypeptide chain the size of 3000 kDa or more (up 
to >38,000 residues) exists in muscle cells. Sequencing demonstrated the presence of 3000-
4000-kDa proteins generated by differential splicing from the copy of a single titin gene. 
Titin has a modular structure consisting of up to 166 Ig-domains, 133 FN3-repeats, and many 
unique sequences. Whereas the A-band titin is constitutively expressed, differential splicing 
of I-band titin gives rise to titin isoforms differing greatly in size in different muscles (Figure 
3). Analysis of the titin genomic structure and further sequencing (Freiburg et al., 2000; Bang 
et al., 2001) established the alternative splicing pathways for human and rabbit titin isoforms 
(Figure 3B). I-band titin has no FN3 domains. Instead it has Ig-domains arranged in tandem. 
Most tandem-Ig modules are grouped in two segments, 'proximal' and 'distal' to the Z-disk, 
flanking a region that has many unique sequences. The Ig-domains in I-band titin are not 
identical; they can be grouped in subfamilies on the basis of sequence homology. The Ig-
domains from different subfamilies are compiled in long-range patterns or 'super-repeats' 
consisting of 6 or 10 domains (Witt et al., 1998).  
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Figure 3. Layout of titin in the sarcomere and I-band titin structure. A. Schematic of the 
sarcomere as a three-filament structure: thin (actin), thick (myosin) and elastic (titin) 
filaments. B. Alternative splicing pathways for I-band titin in human (black arrows) and 
rabbit (blue arrows) soleus and cardiac muscles (modified from Freiburg et al., 2000). 
 
The longest unique sequence is the PEVK-domain (rich in proline, glutamate, valine 
and lysine residues). The PEVK-domain is expressed in the cardiac N2B-isoform as a 190-
residue chain, whereas in other isoforms (skeletal N2A, embryonic cardiac N2BA) it can 
reach up to 2200 residues (e.g., in human soleus muscle) (Labeit and Kolmerer, 1995). There 
are additional unique sequences in I-band titin, e.g., in the so-called N2A-domain (Figure 3). 
Further, the N2B-domain domain is expressed only in cardiac titin isoforms; it contains a so-
called "N2B-unique sequence" (uN2B) which has 572 amino-acid residues (Figure 3). 
Titin isoforms differ in the number of Ig-modules they contain and the length of the 
PEVK-region. Also the presence/absence of the N2B or N2A domain distinguishes the titin 
isoforms. The largest titin isoform sequenced so far is a 3.7 MDa N2A-titin from human 
soleus muscle (Freiburg et al., 2000; Trombitas et al., 2001). In comparison, rabbit psoas-
muscle titin has 3.3-3.4 MDa, whereas human cardiac sarcomeres co-express two isoform 
types, N2BA-titins (3200-3700 kDa) and N2B-titin (3000 kDa). A ~700-kDa titin isoform, 
Novex-3, was discovered by Bang et al. (2001). This isoform seems to be expressed in low 
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abundance in striated muscles, but its function is still unclear.  
I-band titin segment is elastic and extends during skeletal muscle stretching (Fürst et 
al., 1988; Itoh et al., 1988; Whiting et al., 1989; Gautel and Goulding, 1996, Linke et al., 
1996, Linke et al. 1998b). Similarly, I-band titin is a molecular spring in cardiac sarcomeres 
(Linke et al., 1996, Granzier et al., 1997, Linke et al 1998b; Linke 2000). Titin elasticity in 
cardiac myocytes was shown to depend on titin-isoform expression (Linke et al., 1996; 
Cazorla et al., 2000; Freiburg et al., 2000). Interestingly, titin may have a role in the stretch-
dependent enhancement of active myocardial force production (length-dependent activation), 
the basis for the Frank-Starling mechanism (Fukuda et al., 2001; Cazorla et al., 2001). 
The titin springs are anchored in the Z-disk via α-actinin (Figure 4). The amino 
terminus of titin in the Z-disk contains seven titin Z-repeats involved in multiple interactions 
with α-actinin (Ohtsuka et al., 1997; Young et al., 1998). The extreme NH2-terminus binds 
Telethonin (T-cap), which acts as a capping protein for titin (reviewed by Trinick & 
Tskhovrebova 1999, Clark et al. 2002).  
 
 
  
Figure 4. Titin anchorage in the Z-disk. A ~80 kDa region of titin is composed of seven 
repeats of 45 amino-acid residues (Z-repeats). Z-disk titin interacts with telethonin (T-cap) 
and α-actinin, proteins that anchor titin in the Z-disk (adapted from Gregorio et al., 1999). 
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 1.3 Sources of I-band titin elasticity 
 
By using immunolabelling techniques with anti-titin antibodies, the extensibility of I-
band segments was studied in skeletal and cardiac sarcomeres (Linke et al., 1996; Helmes et 
al., 1996; Linke et al., 1998 a, b). Force measurements were performed at different structural 
levels, on single cells (Helmes et al., 1996), single myofibrils (Linke et al., 1996; 1998 a, b) 
and single titin molecules or recombinant titin fragments (Rief et al., 1997; Kellermayer et 
al., 1997; Tskhovrebova et al., 1997). The elasticity of the non-activated sarcomere could be 
described as the sum of the extensible properties of the titin constituting modules (Li et al., 
2002). These studies led to the following titin extension model (Figure 5): at low stretch the 
linker regions between proximal and distal Ig-domains straighten out. With further stretch, 
the PEVK-domain and then the uN2B extend (Linke et al., 1999; Helmes et al., 1999).  
 
 
Figure 5. Sequential extensibility of I-band segments in cardiac titin. At low force, the main 
contribution to the extension of the titin molecule comes from straightening the inter-Ig-
domain linkers. Further extension is provided by the PEVK and the uN2B domains (modified 
from Linke et al., 1999). 
 
Another source of titin extensibility is the unfolding of I-band Ig-domains, which can 
suddenly add substantial length (~30 nm per unfolded domain) to a titin molecule. The rate of 
unfolding depends on the applied force and the rate of stretch (Evans and Ritchie, 1999; Li et 
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al., 2002). Unfolding explains much of the stress relaxation and may constitute a mechanism 
to reset the force to a lower level after the muscle had been extended (Minajeva et al., 2001). 
It may also work as a safety mechanism to prevent overloading the muscle (Tskhovrebova 
and Trinick, 2000; Minajeva et al., 2001). The physiological relevance of Ig-domain 
unfolding is still controversial. Ig-unfolding events occur with high probability only at forces 
reached towards the upper end of the physiological sarcomere-length range. However, even 
lower rates of Ig-unfolding at modest stretch forces could impact the passive tension in 
skeletal myofibrils over much of the physiological length range (Minajeva et al., 2001). At 
zero external force, the free energy of unfolding is between 2 and 10 kcal mol-1, unfolding 
rate constants are in the range 10-2 to 10-6 s-1, and folding rates are between 10-2 and 102 s-1 
(Scott et al., 2002; Head et al., 2001). Titin Ig-domains adopt a beta sheet fold. Between 
antiparallel strands hydrogen bonds are established that can reversibly break under external 
force, thus causing domain unfolding (Carrion-Vazquez et al., 1999). The consequence of 
domain unfolding is that chain tension drops as this event extends considerably the length of 
the stretched segment. Following a stretch, unfolded Ig-domains could refold (Trombitas et 
al. 2003). The ratio between unfolded and refolded domains increases with SL and force 
(Linke and Fernandez, 2003). In turn, when titin molecules are released to zero external 
force, refolding occurs more frequently than unfolding and an equilibrium conformation is 
established.  
 In contrast to the Ig-domains, the PEVK-region has no apparent secondary structure. 
The amino-acid residues of this domain are highly charged at physiological pH. The PEVK-
derived titin contribution to myofibrillar stiffness is ionic-strength dependent and PEVK 
elasticity has been proposed to be based on both entropic mechanisms and electrostatic 
interactions (Linke et al., 1998 a). The PEVK region is considered to adopt random coil 
conformation; however, the repetitive motifs in the sequence (Greaser, 2001) suggest some 
degree of internal organization which possibly has structural and functional consequences. 
 
1.4 Theoretical models of titin elasticity 
Mathematical models of titin elasticity were adapted from elasticity theory developed 
for polymers (Kellermayer et al., 1997; Rief et al., 1997; Tskovrebova et al., 1997). In the 
relaxed state, a polymer adopts a collapsed structure characterized by maximum segmental 
entropy. Under an external force the entropy decreases and an opposing force is generated to 
restore the initial state. The worm-like chain (WLC) model (Marko and Siggia, 1995) of 
entropic elasticity was shown to adequately describe the experimental force-extension curves 
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obtained from titin experiments (Granzier et al., 1997; Linke et al., 1998 a, b). The model 
considers polymers as continuous strings of a given contour length (L) and persistence length 
(A), the latter reflecting the polymer's bending rigidity (stiffness). In the WLC model, the 
external force (f) is related to chain extension (z) through:  
   ,          (1) 
where T is absolute temperature and kB is the Boltzmann constant. The smaller the 
persistence length, the higher is the external force needed to extend the polymer. According 
to this model, titin behaves primarily as an entropic spring capable of fully restoring the 
initial length immediately, once the external force is removed. 
 The titin Ig-domain regions showed a force-extension relation consistent with pure 
WLC behavior (Linke et al., 1998 b) (see Figure 6, inset). In contrast, the PEVK-domain was 
shown to behave like a pure entropic spring at shorter SLs but deviate from this behavior at 
longer lengths (Linke et al., 1998 a). An enthalpy term added to the WLC equation corrected 
the divergence between model and experiment (Figure 6), explainable by the contribution of 
electrostatic interactions to PEVK elasticity. Another experimental indication for an enthalpy 
term was the force hysteresis observed in stretch-release experiments of single myofibrils or 
titin molecules (Minajeva et al., 2001; Kellermayer et al., 2001). Titin thus appears to be 
more a viscoelastic than a purely elastic spring. 
 
 
Figure 6. Force–extension relation of titin segments in rat psoas muscle. The dotted line is a 
fit of PEVK-domain elasticity according to the WLC model, the continuous black line is a 
simulation using the WLC model with an enthalpic contribution. Inset: Pure WLC fit applied 
to the proximal poly-Ig region (from Linke et al., 1998 a). 
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 A recent report showed using two-bead optical tweezers that two entropic springs act 
in series in the I-band of skeletal titin molecules, one assigned to tandem-Ig domains, the 
other to the PEVK-region. The study suggested that an enthalpic component derives in part 
from unfolding of structured elements (tandem-Ig domains) and that also some structures in 
the PEVK-domain contribute to enthalpic elasticity (Leake et al., 2004).  
In cardiac titin, an additional extensible element is the uN2B and the cardiac titin 
isoforms were therefore proposed to be three-element molecular springs (Linke et al., 1999). 
Accordingly, a three-element in-series WLC model readily described the (visco)elasticity of 
human heart titin (Li et al., 2002; Opitz et al., 2004; Makarenko et al., 2004). A source of the 
viscous component is the interaction of titin with actin filaments in the sarcomeres (Kulke et 
al., 2001 b; Minajeva et al., 2002; Linke et al., 2002 a), which cause damped elastic recoil of 
the titin springs from a stretched conformation (Opitz et al., 2003). 
 
1.5 Titin molecules are differentially expressed in various muscle types 
 
Nature has adopted differential splicing of titin isoforms as a way to tune sarcomeric 
passive stiffness. Variation of the total length of the titin molecule is achieved by including a 
variable number of Ig-modules in the titin I-band chain or by altering the number of PEVK 
residues. A longer titin generates less entropic force than a shorter titin at a given SL. 
Mammalian cardiac muscles express not only one major titin isoform (as for example 
soleus or longissimus dorsi muscles do); instead two titin isoforms (N2B and N2BA) with 
different elastic properties are expressed in the myocardium. Linke et al. (1996) demonstrated 
that co-expression of both isoforms occurs at the myofibrillar level. Trombitas et al. (2001) 
showed both isoforms to be co-expressed in the same half-sarcomere. Hence, titin stiffness 
can also be tuned by variation of the titin-isoform composition, while the total number of 
titins in the sarcomere remains fixed at most likely six titin strands per half thick filament 
(Liversage et al., 2001). 
 Recently our group compared the titin N2BA:N2B expression ratios between normal 
and failing myocardium and showed that this ratio indeed varies, which then affects the 
sarcomeric compliance (Neagoe et al., 2002). This work, as well as the titin-isoform 
expression in various species, in various muscles of a given animal, and a map of titin 
isoform expression in heart (Neagoe et al., 2003), will be a focus of this thesis.  
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1.6 Titin and collagen are sources of passive tension in cardiac muscle 
 
Cardiac muscle is a remarkable machine as it functions over a lifetime without 
pausing. Proteins are renewed (turned over) and the effects of excessive stress are 
compensated while the muscle works. However, injuries can cause irreversible damage to the 
heart's structure and function and cause cardiomyopathies and eventually, heart failure. 
 The work produced in a heart cycle (Figure 7) originates in actin-myosin filament 
sliding which changes the SL. The third filament of the sarcomere, the titin, bears the 
mechanical (passive) forces exerted during diastolic filling of the heart chamber. 
 
 
Figure 7.  The heart cycle. Pressure-volume diagram and opening - closure events occurring 
with the mitral and the aortic valves during one cycle of the heart. Titin is a major contributor 
to the A-B segment, which represents the diastolic filling. 
  
  Ventricular wall resilience results from several contributions. Titin is, together with 
collagen/connective tissue, a main determinant of the end-diastolic pressure (Linke et al., 
1994; Granzier and Irving, 1995). At SLs lower than 2.2 µm the tension in a cardiac muscle 
strip is generated by titin (Linke et al., 1994). Extracellular collagen fibers are rigid structures 
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and probably slack when the sarcomeres are shorter than 2.2 µm. They are likely to limit 
further extensibility of the muscle once they become stretched at >2.2 µm SL (Figure 8). 
   
 
Figure 8. Sources of passive tension in cardiac muscle. Comparison of the passive tension-
extension curves obtained from muscle strips (containing extracellular structures) and 
myofibrils (where titin is the main determinant of stiffness). At SLs above 2.2 µm, collagen 
determines a steep rise in the passive tension response of the muscle. Inset: phase image of 
myofibril specimen; scale bar, 5 μm (from Linke et al., 1994, 2000, 2002 b). 
 
1.7 Heart failure can be associated with defects in cytoskeletal proteins 
 
 Heart failure is defined as a state of the myocardium in which cardiac function is 
impaired. Work output is not sufficient to adequately supply metabolic nutrients and oxygen 
to the body. Ischemic heart disease, valve defects, hypertension, or cardiomyopathies, all may 
evolve to heart failure. Progression from cardiac abnormalities to heart failure involves 
changes in the expression of many proteins. In the early phase of compensated myocardial 
hypertrophy the ventricular mass is increased with the tendency to normalize the wall stress. 
From this point on, the influence of yet-undefined stimuli may lead to decompensated 
cardiomyopathy characterized by cellular atrophy and interstitial fibrosis.  
Hereditary defects in genes coding for sarcomeric proteins or in genes coding for 
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cytoskeletal proteins have been associated with cardiomyopathies. Familial hypertrophic 
cardiomyopathy (FHC) appears to be primarily a disease of the sarcomere, as most of the 
disease-causing mutations are found in genes encoding sarcomeric proteins, i.e., beta-myosin 
heavy chain, MyBP-C, alpha-tropomyosin, troponin I, troponin T, actin, or titin. In contrast, 
multiple lines of evidence support the concept that heart failure resulting from inherited 
forms of dilated cardiomyopathy (DCM) may occur primarily due to defects in the expression 
of cytoskeletal proteins (for review see Bowles et al., 2000), e.g., in genes encoding 
dystrophin or actin. In another example, mutations in the 53-kDa protein desmin, which 
contributes to cytoskeletal organization in muscle by connecting sarcomeres through their Z-
disks and stabilizing the muscle structure, cause DCM by weakening these connections (Li et 
al., 1999). As for titin, cardiomyopathy-causing mutations have been described in the Z-disk 
region, the Z-I transitional zone, the N2B-domain, and the A-band region (Gerull et al., 
2002). Mutations in the titin gene were found in human and zebrafish hearts. 
Cardiomyopathies are not only caused by gene mutations. Environmental factors can 
be another stressor leading to heart disease. For example, ischemia caused a shift in myosin 
heavy chain expression from the fast type to the slow type, presumably diminishing the 
energy utilization rate during a heart cycle (Schaub et al., 1997, and references therein). 
Myocardial isoform switching could be a general phenomenon associated with many types of 
heart disease. Titin was earlier shown to be disrupted in idiopathic DCM, which was 
interpreted as proteolytic damage to the titin filaments and consequently deficiencies in force 
transmission and mechanical stress handling (Hein et al. 1994; Morano et al. 1994). These 
conclusions were drawn based on the results of immunofluorescence microscopy studies on 
tissue sections using anti-titin antibodies. In my thesis, a goal was to determine whether titin-
isoform expression is altered in two types of human cardiac disease, ischemic coronary artery 
disease (Neagoe et al., 2002) and non-ischemic DCM (Makarenko et al., 2004). The results 
will be presented and commented below. 
 
1.8 Cardiac titin and active muscle contraction 
 
 Systole is powered by active force production in the sarcomeres, but what about the 
elastic energy stored during diastole? Is it lost as heat or is it converted into work to support 
muscle contraction? Experiments showed that titin-derived elastic forces in stretched skeletal 
myofibrils cause very fast passive shortening under zero external loads (Minajeva et al., 
2002). Under active conditions, the passive elastic recoil of titin could still support active 
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contraction in the very early phases of shortening. Similar conclusions were drawn from 
experiments on human cardiac myofibrils. It was proposed that the passive elastic energy 
stored in the titin springs helps the early phase of active shortening, before titin elastic recoil 
is quickly damped by viscous resistive forces (Opitz et al., 2003). 
Increased viscosity inside cardiomyocytes has long been known to alter cardiac 
function, as viscosity interferes with filament sliding and can limit the shortening velocity of 
cardiac sarcomeres. A viscous force was initially experimentally observed in cat papillary 
muscle at moderate stretch velocities (Noble, 1977). This viscous force was later proposed to 
originate in the microtubule network and/or weak cross-bridge interactions. Recently it was 
shown that a viscous force arises from titin-actin interactions (Kulke et al., 2001 a; Yamasaki 
et al., 2001; Linke et al., 2002 a) and more precisely, from interactions between actin and 
titin’s PEVK-domain. This drag force was temperature and calcium dependent (Kulke et al., 
2001 a). The length of the PEVK region is subject to substantial variations owing to 
alternative splicing of titin isoforms. Thus, changes in titin-isoform expression could also 
modify the viscous properties of the sarcomere, e.g., in heart disease. 
 An essential mechanical property of the heart is the preload-dependent force 
enhancement in the active contraction phase, best known as the Frank-Starling law of the 
heart. The molecular basis for this phenomenon is still unknown, but involves an increase in 
calcium sensitivity of active force production upon stretch of the muscle. Interestingly, when 
titin was selectively degraded by very low concentrations of trypsin, passive tension dropped 
and cardiac fibers lost their ability to become sensitized to Ca2+ by stretch (Cazorla et al., 
2001; Fukuda et al., 2001). Titin could thus play a role in length-dependent activation (LDA). 
A possibility is that titin affects the lateral filament spacing between actin and myosin 
filaments (Figure 9), which has been suggested to be important for LDA (Moss and 
Fitzsimons, 2002). 
Another proposal to explain LDA in cardiac fibers is based on the fact that titin 
strands and thick filaments are bound together in the A-band region (Muhle-Goll et al., 
2001). The strain imposed by stretch of the sarcomere may be transmitted via I-band titin to 
the A-band section of titin, thereby affecting myosin head periodicity and/or motor properties 
of cross-bridges. However, additional investigations are required to directly link titin and the 
Frank-Starling mechanism. 
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Figure 9. Myofilament arrangement and illustration of how titin could control lattice spacing 
(from Moss and Fitzsimons, 2002). A radial component of titin-based tension exerts 
compression on the space between actin and myosin filaments (lattice spacing). The 
probability of crossbridge interaction may increase at long SLs, since actin filaments and 
crossbridges are closer to each other.  
 
 
The Frank-Starling mechanism is sometimes compared to the stretch activation 
response seen in insect indirect flight muscles (IFM), although these two phenomena may be 
unrelated (Vemuri et al., 1999). Interestingly, there are two homologues of titin in IFM, kettin 
and projectin (Kulke et al., 2001 a). Recently it was suggested that expression of different-
length kettin-isoforms modulates the passive tension in Drosophila IFM (Leake et al., 2003), 
perhaps influencing stretch activation. Similarly, altered titin-isoform expression (e.g., in 
failing hearts) could affect the ability of the heart to sense the diastolic preload. 
 
In conclusion, investigation of cardiac titin expression is relevant for understanding at 
the molecular level the mechanical properties of cardiac muscle, particularly in diastole but 
also in systole. This thesis was aimed at determining the role of titin in normal and diseased 
hearts. A focus was the titin-isoform diversity in different muscle types and the pathological 
changes in cardiac titin expression and function in human hearts. Most results shown and 
discussed here have been published in original peer-reviewed research articles. 
 25
2. MATERIALS AND METHODS 
 
2.1 Tissue 
 
2.1.1 Human heart tissue 
 
 Studies on human heart (HH) tissue were approved by the Subcommittee on Human 
Research at Massachusetts General Hospital. Left ventricular samples (anterolateral midwall) 
from 29 HHs were collected in accordance with the approved guidelines. Samples were 
classified in 5 groups: 
1) CAD transplant – hearts from patients with coronary artery disease (CAD) characterized 
by a history of multiple infarcts; New York Heart Association (NYHA) class III-IV; 
2) CAD donor – hearts that show significant signs of CAD but no antecedents of diagnosed 
heart disease; 
3) non-ischemic transplant - hearts transplanted for reasons other than CAD; 
4) DCM transplant – hearts diagnosed with dilated cardiomyopathy (DCM) and explanted in 
transplantation surgery; NYHA class III-IV; 
5) normal donors – non-failing hearts obtained from brain-dead human donors, for which 
normal LV function had been confirmed by echocardiographic evidence. 
From these hearts, non-necrotic regions were studied as detected by gross examination of the 
ventricles cut in transverse sections. Transplant HH were transported for ~1 h and donor HH 
for 1 to 5 h in cardioplegia, then deep frozen at –80°C. 
 
2.1.2 Tissue samples and preparation of myofibrils 
 
 Laboratory animals were sacrificed according to institutional guidelines. In most 
cases the animals were obtained from the University of Heidelberg' s animal house. 
Occasionally tissue was obtained from local slaughterhouses in Heidelberg. Rat samples with 
a ligature of the left anterior descending coronary artery (LAD) were from animals used in a 
previous study by Dr. Pieter de Tombe, University of Illinois, USA; animals were purchased 
from Charles River Laboratories. Frozen heart tissue was shipped to Heidelberg on dry ice.  
 The following muscles were of particular interest: heart, soleus, and psoas major. 
Skeletal muscles were rinsed and hearts perfused with ~20 ml of extracellular solution "Rigor 
1" (see 2.4 Solutions). Hearts were dissected, the LV separated from the RV, and tissue 
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quickly frozen in liquid nitrogen. In some cases trabecular fibers (3-5 mm long and 200-400 
μm thick) were cut from freshly excised LV tissue. Muscle strips (~1 mm thick and 1-2 cm 
long) were cut along the fiber orientation, the ends tied to a glass rod, and then skinned in 
0.5% Triton X-100 / Rigor 2 buffer supplemented with leupeptin (40 μg/ml) for 4 to 12 h 
(4°C, under continuous shaking). In case of human hearts the muscle fibers were dissected 
from frozen tissue. The Triton X-100 was washed out with Rigor 2 buffer and the fibers were 
incubated for 1h in ice-cold Rigor 2 buffer + leupeptin. When not prepared for fiber 
mechanical measurements, the strips were used to obtain myofibrils. Fibers were minced and 
homogenized with an Ultra Turrax homogenizer (IKA-Werke, Hannover, Germany). At the 
end of the procedure one could find structurally intact, isolated myofibrils in the myofibril 
suspension. 
 
2.2 Antibodies 
2.2.1 Primary antibodies 
 
 The following anti-titin antibodies were used: MG1 to N2BA-titin (N2A domain), 
N2B to N2B domain and BD6 to all titin isoforms (Whiting et al., 1989; Linke et al., 1999; 
Gautel et al., 1996). For epitope localization, see Figure 10. Cardiac troponin I, cTnI, was 
detected with antibody 8I-7 (Spectral Diagnostics, Canada) (McDonough et al., 1999; Feng et 
al., 2001). To identify collagen I and collagen III, COL1 or FH-7A were used (Sigma-
Aldrich). Desmin antibodies were from Progen Biotechnik (Germany). 
 
 
 
Figure 10. Sequence assigned titin antibodies used for this study: localization of the 
respective epitopes on N2BA-titin (from Neagoe et al., 2002). 
 
2.2.2 Secondary antibodies 
 
All secondary antibodies were purchased from Sigma-Aldrich. For fluorescence 
microscopy, Cy3 or FITC dyes conjugated with anti-rabbit or anti-mouse IgG antibodies 
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were used. Dilutions were used in the range recommended by the supplier. Peroxidase 
labelled anti-rabbit and anti-mouse secondary antibodies was used for Western blot. Control 
experiments were done with each secondary antibody to detect possible non-specific cross-
reactivity. Results were generally negative. 
 
2.3 Methods 
 
2.3.1 Immunofluorescence microscopy on isolated myofibrils 
 
 To measure the extensibility of titin domains in myofibrils, immunofluorescence 
microscopy was performed according to the following protocol. A drop of the myofibril 
suspension was placed on a glass coverslip under an inverted phase contrast microscope 
(Zeiss, Axiovert 135; Jena, Germany).  Then, two glass microneedles were prepared using a 
horizontal micropipette puller and each glass needle was attached to a hydraulic 
micromanipulator (Narishige, Japan). A mixture of water-curing silicon glues, RTV3145 and 
RTV3140 (Dow Corning, USA), was prepared and, with the help of a third glass needle 
controlled by a mechanical micromanipulator, placed on the tip of the two other needles. The 
two glue-coated needle tips were then softly pressed against the ends of a desired myofibril 
specimen. After 5 min the ends of the myofibril were rigidly attached to the tips of the glass 
needles. At this point the rigor incubation solution was replaced by ATP containing solution 
(relaxing buffer) top help prevent structural damage from overly stretching the myofibrils.  
Sarcomeric structures were visualized using a 100x oil-immersion objective (Plan 
Neofluar, Zeiss, Jena: numerical aperture 1.3). Myofibrils were examined for a regular 
striation pattern suggesting structural preservation and stretched to a desired SL. Phase 
contrast and fluorescence images were recorded with a CCD color video camera (Sony, AVT 
Horn). 
The sample was incubated with appropriate concentrations of primary antibodies 
(typical dilution in relaxing buffer, 1:50 to 1:100) for ~30 min. Then the antibody solution 
was washed out with relaxing buffer (3 times wash) and the FITC or Cy3 conjugated 
secondary antibody was applied for another 30 min, before the specimen was washed 
extensively (initial volume of the solution exchanged ~4 times). Images were recorded in the 
epifluorescence mode of the microscope (example in Figure 11) using a 100 W arc lamp. 
Care was taken to minimize the exposure times to prevent extensive photo bleaching of 
fluorophores. 
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Figure 11. Typical experiment to determine segmental extensibility of I-band titin. A frog 
single cardiac myofibril was stained with an I-band titin antibody. The relative extension of 
the epitope to Z-line segment versus SL could be determined by measuring the closest 
distance between adjacent epitopes at different stretch states.  
 
The distance between fluorescent epitopes was measured on digitized fluorescence 
images and the epitope position compared with the corresponding phase image, which was 
also used to measure SL. Because the epitopes appeared as relatively broad stripes 
(diffraction limit), the center-of-mass of the intensity signal was calculated from intensity 
profile plots along the myofibril axis (Linke et al., 1998 a). Data points obtained from many 
myofibrils were pooled into an epitope-distance versus SL diagram. The same procedure was 
repeated for other titin antibodies. The extensibility of a given titin segment was calculated 
by measuring the difference between the respective epitope-versus-SL curves. 
 
2.3.2 Force measurements on myofibrils 
 
 A myofibril specimen was attached at one end to a force transducer and at the other 
end to the tip of a glass needle connected to a piezoelectric micromotor. Movement of the 
force transducer and gross displacement of the motor were controlled with the 
micromanipulators. Precise and rapid movements were imposed onto the specimen by 
controlling the piezoelectric motor, e.g., fast stretch-release oscillations to measure 
myofibrillar passive stiffness or a defined succession of stretch and hold steps followed by 
stepwise releases to measure passive force. 
The principle of the force transducer is that an optical glass fiber is bent when a force 
is applied at the free end. As the ends of the specimen are glued to the micromotor and force 
transducer, respectively, movement of the motor needle at one end will induce changes in 
myofibrillar force which are transmitted to the force transducer. The end of the optical glass 
fiber is thus deflected and the deflection of this fiber (which is emitting white light) produces 
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a displacement of the light beam. This displacement is recorded by two receive optical fibers, 
whose light signal is transformed into electric current by a photodiode. Differential analysis 
of the two receive-fiber channels is done by an electronic module which transforms the two 
inputs into a single channel voltage signal (ΔV) proportional to the displacement, δ, of the 
emitting fiber tip. Knowing the Young’s module, E (~7,7·1011 mg/cm2), for the glass fiber 
and the bending rigidity of the fiber, one can calculate the bending force, f, according to: 
f = 3δ·Ε·Ι / l3 ,         (2) 
where L is the length of the optical fiber and I is the geometrical moment of inertia, given by: 
 I = π·d4 / 64  .                (3) 
The relation between δ and ΔV is linear and should be established prior to each experiment 
by measuring the voltage change upon a known displacement of the optical fiber tip. 
A National Instruments data acquisition board and custom written Labview software 
were used to control motor movement and data output and display and analyze (e.g., filter) 
the data.  For details see Kulke et al. (2001 b). All force measurements on myofibrils were 
done in non-activating (relaxing) buffer in the presence of active-force suppressor, 2,3-
butanedione monoxime, BDM. Passive tension was calculated by relating the force to the 
cross-sectional area of the specimen inferred from the myofibril diameter. 
 
2.3.3 Proteolytic titin digestion by low-dose trypsin 
 
 To test whether titin is responsible for sarcomeric stiffness, specific proteolysis was 
performed using low concentrations (0.25 μg / ml) of trypsin. Trypsin is known to degrade 
almost all peptides, but at low enzyme concentrations muscle samples incubated with trypsin 
show rapid and dramatic, selective, titin degradation indicated by the appearance of a strong 
“T2” titin band on SDS-PAGE gels (presumed to be a proteolytic product of native titin). In 
contrast, bands for other muscle proteins seem to be unaffected by mild trypsin digestion 
(Cazorla et al., 1999). Rapid loss (within 3 to 10 min) of myofibrillar passive tension was 
observed during trypsin treatment (0.25 μg/ml in relaxing solution) (Kulke et al., 2001 b). 
 
2.3.4 Immunofluorescence microscopy on tissue sections 
 
 In situ examination of muscle proteins was done by immunofluorescence microscopy 
on tissue sections fixed with paraformaldehyde (PFA). Procedures for immunofluorescence 
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on tissue sections were performed using PBS solutions. Muscle fibers were incubated on ice 
in PBS containing 4% PFA overnight and were then transferred to 10% sucrose solution 
(4°C) for 24 hours. Thin sections (20 μm thick) were cut at –20°C and stored in PBS on ice. 
 A standard protocol for tissue immunofluorescence microscopy was applied 
(modified from Antohe et al., 1999). Briefly, sections were incubated for 10 min in PFA-Tx, 
10 min in 50 mM NH4Cl, 10 min in 2%BSA / PBS-Tx, and then 2 h with primary antibody 
(in 2% BSA / PBS). Sections were washed 3 x 10 min with PBS-Tx, then incubated for 2 h 
with the fluorescently labelled secondary antibody and washed 3 x 10 min. The section in 
PBS-glycerol was placed on a glass slide and a cover slide was put on top. The specimen was 
examined under the inverted fluorescence microscope (Zeiss Axiovert 135) and images were 
recorded by the CCD color camera as noted above. 
 
2.3.5 Sample solubilization and protein concentration measurements 
 
 Tissue strips (~1 cm long and 3 mm wide) were cut from frozen ventricle and 
immediately put in 1.5 ml reaction tubes with ice cold solubilization buffer. Samples were 
boiled (100°C) for 3 min, then centrifuged for 3 min at 16 000 x g. Approximately 2 μl of 
sample were taken to determine the protein concentration. 
 The total protein content of the samples was analyzed spectrophotometrically using 
the Bradford method (BioRad Protein Assay) according to instructions by the supplier. 
Absorbance was read at 595 nm wavelength and protein concentration was calculated from 
the optical density using a standard curve as reference. For titin analysis, optimal protein 
loading on gels was 50-80 μg / lane. 
 Myofibrillar fraction assay. Muscle pieces were homogenized in 50 μl relaxing 
buffer. Subsequently 1 ml relaxing buffer was added, the sample was centrifuged and the 
supernatant placed in a separate tube for TnI western blot analysis. SB-buffer was then added 
to the pellet and supernatant. 
 
2.3.6 SDS polyacrylamide gel electrophoresis 
 
 Standard polyacrylamide gels were prepared by the protocol of Laemmli (1970). Gels 
with various acrylamide concentrations (from 1.8% to 18%) and sometimes gels with a 
concentration gradient were made.  
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2.3.6.1  Titin detection on 2% SDS-polyacrylamide gels  
 
Large MW proteins, like titin, need a low porosity gel matrix in order to run a 
measurable distance in the electric field. However, these gels are very fragile. Tatsumi and 
Hattori described in 1995 a method to give mechanical strength to low porosity gels by 
adding agarose (0.5%) to the gel components. In the present work the Biometra Minigel-
Twin system (Biometra biomedizinische Analytik GmbH, Göttingen) was used to study titin 
by gel electrophoresis. The design is optimized for separation of proteins in vertical 8.6 x 7.7 
cm gels. The glass plates have fixed spacers and the sealing is obtained with one-piece 
silicone rubber seals. 
Pre-warmed (50°C) gel solution (AA-BA) was mixed (for recipe see section 2.4 
Solutions) and agarose (1.5% stock) was boiled in the microwave oven. Appropriate volumes 
of agarose and acrylamide-bisacrylamide solution were mixed to reach the desired agarose 
concentration. APS was added and the mixture was quickly loaded to the moulds of the gel 
chamber. Immediately thereafter a comb to form the loading pockets was put on top of the 
gel, which was left to polymerize for a minimum of 2h at 4°C. The final agarose 
concentration, which determines the mechanical properties of the gel, varied between 0.4% 
and 1%. Acrylamide concentrations ranged from 1.8% to 2.8%, the latter was used to 
visualize titin and myosin heavy chain (MHC) on the same gel. 
 After polymerization the gel was placed in the running chamber, and the solubilized 
samples were loaded (2-18 μl per lane). The best separation for the high molecular weight 
proteins was obtained by running the electrophoresis overnight at 2 mA per gel. Gels were 
then taken out from the glass mould and stained by Coomassie blue for 1 h using staining 
solution (coomassie blue dye, 40% methanol, then 10 min in 50% ethanol / 7% acetic acid, 
and 2-4 h in 5% ethanol / 7% acetic acid. Silver staining was performed with Bio-Rad Silver 
Stain Kit (Bio-Rad Laboratories, USA) according to the recommended protocol. Gels were 
scanned wet and dried on paper or between cellophane foils using a Biometra Gel-Dryer 
system.  
Calibration of titin gels. To estimate the molecular weight of a protein by gel electrophoresis 
one typically uses molecular weight (MW) markers and an interpolation method. The method 
does not work for titin, as there are no commercial MW markers available in this size range. 
The assumption for 2% polyacrylamide gels is that the running distance increases 
exponentially as the molecular weight of the protein decreases (Wang and Wright, 1988; 
Wang et al., 1991; Granzier and Irving, 1995). Calibration can be done using titin and nebulin 
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with known MW size as reference markers.  For instance, rabbit soleus titin has a molecular 
weight of 3.6-3.7 MDa, whereas rat heart expresses almost exclusively the ~3.0 MDa N2B-
titin isoform. Rabbit nebulin is around 750 kDa. 
  Although titin and MHC could be visualized on 2.8% polyacrylamide gels on the 
same gel lane, the huge size difference between the two proteins made a determination of the 
molar ratio difficult, as the stainability of these proteins is different (Neuhoff, 1990). 
Nevertheless, the molar ratio between MHC and titin could be calculated with reasonable 
precision, suggesting 3 to 6 titin molecules are present per half thick filament (Liversage et 
al., 2001). A substantial effort was made to quantify titin expression in samples from diseased 
and normal muscles (Neagoe et al. 2002, Wu et al. 2002, Anderson et al. 2002, Hunter et al. 
2003). 
 
2.3.6.2 SDS-polyacrylamide gradient gels 
 
High AA-BA and low AA-BA concentration solutions were prepared (see 2.4 
Solutions) to make polyacrylamide gradient gels. The gradient forming device consisted of 
two tubes communicating through a pipe located at their bottom. One of the tubes had 
another pipe at its bottom side to let the mixture of acrylamide solutions flow into the gel 
mould. All pipes had valves with an open-closed mode of operation. Each acrylamide 
solution was put in a tube of the mixing chamber, stirred, and APS was added to each tube. 
The valve between the tubes was opened, then the outflow valve was opened and the gel 
mould filled with the solution from the mixing chamber. Because of the density gradient, the 
solution with a high AA-BA concentration flows faster and is deposited at the bottom of the 
gel. The low AA-BA concentration solution was mixed with the high AA-BA concentration 
solution and the solutions passed from one chamber to the other via the communicating tube. 
The result was a gradient in AA-BA concentration increasing from the top to the bottom of 
the gel. 
 
2.3.6.3 Gel image acquisition and analysis 
 
Digital pictures of the stained gels were taken using a through-light scanner 
(Scanmaker E6, Microtek) in the "positive transparency" scanning mode. Optimum scanning 
resolution was considered to be 600 dpi on a 256 greyscale. Optical volumes (OVs) of the 
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bands were calculated using TotalLab software (TotalLab, Phoretix, USA). MW size was 
estimated using an algorithm in which a logarithmic relationship between running distance 
and MW was assumed. 
 
2.3.7 Western blot 
 
 Western blotting was employed to identify the titin isoforms, cTnI, MHC, and 
desmin. The SDS-PAGE gel, PVDF membrane and pieces of Whatman paper were rinsed in 
ice cold TB. Then a sandwich consisting of paper, gel, PVDF membrane, and again paper, 
was built and put in a transfer tank with TB. The setup was connected to a DC power source. 
The time and the electric parameters for the protein transfer depended on the molecular 
weight of the band to be transferred: the larger the protein, the higher the charge for transfer 
(Q), where Q = i * t is the product of current intensity and transfer time. For titin, an optimal 
transfer was achieved at 700 mA for 6h. Active cooling was used to dissipate excessive heat. 
 After electrotransfer, the membrane was washed 2 x in TBS-Tx. Then it was checked 
by Poinceau red staining whether protein bands were present on the membrane. Poinceau 
solution was washed away with TBS and the membrane was incubated for 2 h with 2% BSA / 
TBS solution to block unspecific binding sites. Procedures were done at room temperature. 
The primary antibody incubation time was 1h in BSA / TBS buffer. Then, the membrane was 
washed 1 x 15 min + 2 x 5 min with TBS, incubated for 30 min with the secondary 
peroxidase-conjugated antibody (dilution 1:70,000 in TBS-Tx; Sigma-Aldrich) and washed 1 
x 15 min + 3 x 5 min. Incubation with the secondary peroxidase-conjugated antibody only 
was done as a control to test for non-specific primary antibody reaction.  
Chemiluminescent assay. Visualisation of the protein bands on the blot membrane 
was done using the light emitted when luminol is oxidized by H2O2, a reaction catalyzed by 
peroxidase. For the present work I used an ECL chemiluminescent kit (Amersham Pharmacia 
biotech). It consists of two solutions mixed in equal volumes just before use. 
Chemiluminescent reaction was recorded on autoradiography film (Kodak X-Omat XAR 5; 
manoeuvre performed under red light) in an autoradiography cassette. After one, three, or ten 
minutes, the film was removed, developed, fixed (Kodak kit) and dried. The picture was 
scanned and analysed in the same way as described for gels. 
 In some experiments it was necessary to test different antibodies on the same 
membrane. To do so, the bound antibodies were stripped off by incubation with reprobing 
buffer for 30 min at 50°C. 
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2.3.8  Force and shortening velocity measurements on muscle fibers 
 
Passive and active isometric force or maximum unloaded shortening velocity 
(according to Edman, 1979) were measured in skinned cardiac trabeculae or psoas muscle 
fibers obtained from freshly excised rat or rabbit hearts and skeletal muscle. 
The diameter and the length of the fibers were measured under a binocular 
microscope. Usual dimensions were 0.15-0.4 mm (thickness) by 2-4 mm (length). In a typical 
experiment the ends of a skinned fiber were attached via miniature stainless steel tweezers to 
a force transducer and a linear moving motor (Muscle Research System apparatus; Scientific 
Instruments, Heidelberg) (Figure 12). Custom written software (thanks to Mr. Uros Krzic) 
was used to drive the apparatus in stretch (release)-force acquisition protocols. Nonactivated 
specimens were slowly stretched to a desired SL. Sarcomere length was measured by laser 
diffraction using a laser diode emitting at a wavelength of 670 nm. The fiber bundle was left 
to equilibrate for 5 min in the equilibration solution 1, then the preparation was transferred to 
activating solution. 
 
 
 
Figure 12. Experimental setup for isometric force, isotonic shortening and slack test 
measurements. The muscle fiber was attached via miniature stainless steel tweezers to a 
linear motor and a force transducer. Length and diameter of the specimen were measured 
under a binocular microscope. Sarcomere length was determined by laser diffraction. The 
wells contained various solutions with different Ca2+ concentrations.  
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2.3.9 Isolation and culture of adult rat cardiomyocytes 
 
 Female Sprague-Dawley rats (2-month old) with a body weight of 200-220 g were 
anesthetized and the heart was excised. Then the heart was perfused retrogradely via the aorta 
with Joklik medium (gassed with a 5% CO2 : 95% O2 mixture) for about 10 minutes. The 
perfusion continued for another 35 min with Joklik medium containing collagenase 2 (see 2.4 
“Solutions”). The heart was cut off below the atria and chopped into fine pieces, then washed 
with “Kraftbrühe” solution (see 2.4 “Solutions”). The tissue was further treated with 
collagenase / Kraftbrühe solution in a 37°C water bath under shaking. The digested tissue 
was carefully pressed through a Nylon filter and the resulting cell suspension centrifuged. 
The pellet of cells was transferred to Joklik medium containing 0.5 mM CaCl2, mixed and 
again centrifuged.  
 Cells were recovered as pellet and cultured for 2 h in M199 medium (Gibco) + 5 mM 
creatine at 5% CO2 atmosphere, 37°C, then the cell suspension was centrifuged and 
recultured in medium M199 supplemented with serum (10%), antibiotics (1%), and cytosine 
arabinoside (see 2.4 “Solutions”). The culture plates had previously been coated with 
collagen R (Serva) according to the manufacturer’s recommended protocol. After 2 days the 
medium was exchanged and such medium exchange was repeated every 5 days as described 
(Eppenberger-Eberhardt et al., 1997). 
 
 
2.4 Solutions 
 
2.4.1 Solutions for immunofluorescence microscopy on tissue sections 
 
Phosphate Buffered Saline (PBS)
16 g NaCl, 0.4 g KCl, 3 g Na2HPO4 * 2H2O, 0.4 g KH2PO4
 
Paraformaldehyde / glutaraldehyde fixation solution (PFA / GA)
Paraformaldehyde (4%) was dissolved in H2O by stirring and heating to 50-60°C. Then the 
solution was clarified with several drops of 1 M NaOH and the pH adjusted to 7.1 using HCl. 
Aliquots of 10 ml were prepared and frozen at –200C. Optionally, 0.8% glutaraldehyde could 
be added just before use.  
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2.4.2 Solutions for muscle fiber preparation and myofibril mechanics 
 
Rigor solution 1 ("extracellular")
132 mM NaCl, 5 mM KCl, 7 mM glucose, 1 mM MgCl2 , 4 mM TES, 5 mM EGTA, pH 7.1 
(adjusted with KOH). 
 
Rigor solution 2 ("intracellular")
75 mM KCl, 10 mM Tris, 2 mM MgCl2 , 2mM EGTA, 40 μg/ml leupeptin, pH 7.1 (adjusted 
with KOH). 
 
Relaxing solution pCa 9.2 
9.2 mM Mg-methanesulfonate, 12 mM K-methanesulfonate, 3.2 mM Mg-ATP, 130 mM 
MOPS, 15.5 mM EGTA, 40 μg/ml leupeptin (Peptide Institute, Osaka, Japan), pH 7.1 
(adjusted with KOH). 
 
Equilibration solution 1 
20 mM imidazole; 2 mM EGTA; 10 mM MgCl2; 7.5 mM ATP; 1 mM NaN3; 10 mM creatine 
phosphate,  pH 7.0 (adjusted with KOH). 
 
Activating solution pCa 4.5 
20 mM imidazole; 2 mM EGTA; 10 mM MgCl2; 7.5 mM ATP; 1 mM NaN3; 10 mM creatine 
phosphate,  4 mM CaCl2  (pCa 4.5), pH 7.0 (adjusted with KOH). 
 
2.4.3 Solutions for SDS-PAGE 
 
Standard x % separation gel (Laemmli)
A desired amount (x %) (w/v) acrylamide mixture (30:0.8 acrylamide : bisacrylamide), 375 
mM Tris (pH 8.8), 0.1% (w/v) SDS, 0.005 (v/v) TEMED, then 0.05% (w/v) APS added to 
start the polymerization. An example is as follows: 
 
8%-gel, volume for 2 minigels 
 
stock solution       volume 
Acrylamide : bisacrylamide (30% / 0.8%)  4 ml 
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Glycerol : H2O     0.75 ml 
Lower Tris (1.5 M Tris, 0.4% SDS, pH 8.8)  3.75 ml 
20% SDS      0.1 ml 
H2O       6.4 ml 
TEMED      7.5 μl  
10% APS      75 μl  
 
Concentration (stacking) gel  3%
3% (w/v) acrylamide, 125 mM Tris (pH 6.8), 0.1 % (w/v) SDS, 0.02% (v/v) TEMED, then 
0.6% (w/v) APS added to start the polymerization. 
 
Gradient gels 
 
1.8 to 10% gradient, volume for 2 minigels 
 
"1.8%" solution (take 4 ml / gel) 
stock solution      volume 
Acrylamide : bisacrylamide (30% / 0.8%)  0.54 ml 
Lower Tris (1.5 M Tris, 0.4%SDS, pH 8.8)  4 ml 
H2O       4.38 ml 
TEMED      5 μl   
10% APS      18 μl 
 
"10%" solution 
stock solution      volume 
Acrylamide :  bisacrylamide (30% / 0.8%)  2.67 ml 
Glycerol : H2O (1:1 v/v)    1 ml 
Lower Tris (1.5 M Tris, 0.4% SDS, pH 8.8)  4 ml 
H2O       0.29 ml 
TEMED      3.75 μl 
10% APS      18 μl 
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10 to 18% gradient, volume for 2 minigels 
 
"10%" solution (take 4 ml / gel) 
stock solution      volume 
Acrylamide : bisacrylamide (30% / 0.8%)  5.52 ml 
Lower Tris (1.5 M Tris, 0.4% SDS, pH 8.8)  4 ml 
Glycerol : H2O (1:1 v/v)    1.2 ml 
H2O       5.52 ml 
TEMED      8 μl   
10% APS      18 μl 
 
"18%" solution (take 3.5 ml / gel) 
stock solution      volume 
Acrylamide /  bisacrylamide (30% / 0.8%)  9.6 ml 
Glycerol      2.4 ml 
Lower Tris (1.5 M Tris, 0.4% SDS, pH 8.8)  4 ml 
TEMED      8 μl 
10% APS      18 μl 
 
Low acrylamide concentrations (1.8% to 2.8%) in agarose-strengthened gels
For 0.5% (w/v) agarose, stock 1.5% is melted and an appropriate amount is mixed with AA-
BA solution. For AA-BA solution, 2% (w/v) acrylamide (30 : 0.8), 375 mM Tris (pH 8.6), 
0.1% (w/v) SDS, 0.075% (w/v) APS, 0.06% (w/v) TEMED are mixed. Examples are as 
follows: 
 
2% gel, volume for 2 minigels 
stock solution      volume 
Acrylamide : bisacrylamide (30% / 0.8%)  1.3 ml 
Lower Tris (1.5 M Tris, 0.4% SDS, pH 8.8)  5 ml 
20% SDS      0.1 ml 
H2O       5.9 ml 
TEMED      11.5 μl  
The mixture is prepared in a 50 ml plastic tube, warmed to 50°C, and the following is added: 
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10% APS      0.150 ml   
1.5% agarose (melted in a microwave oven)  6.65 ml 
 
2.8% gel, volume for 2 minigels 
stock solution      volume 
Acrylamide : bisacrylamide (30% / 0.8%)  1.533 ml 
Lower Tris (1.5 M Tris, 0.4% SDS, pH 8.8)  5 ml 
20% SDS      0.1 ml 
H2O       4 ml 
TEMED      11.5 μl  
The mixture is prepared in a 50 ml plastic tube, warmed to 50°C, and the following is added: 
10% APS      0.150 ml   
1.5% agarose (melted in a microwave oven)  5 ml    
       
Running buffer
25 mM Tris (pH 8.3), 192 mM glycine, 0.1% (w/v) SDS 
 
Sample solubilization buffer
4.3 mM Tris, 4.3 mM EDTA, 1% SDS, 1% 2-mercaptoethanol, 10% (v/v) glycerine, 0.1% 
(w/v) bromophenol blue, 4 μg/ml leupeptin  
 
Staining solution
0.1% (w/v) Coomassie Brilliant Blue G250, 7% (v/v) acetic acid, 40% (v/v) methanol. 
The recipient is covered, the solution is stirred for more than 2 h, and then filtered. 
 
Destaining solutions (in v/v)
a) 50% ethanol, 7% acetic acid 
b) 5% ethanol, 7% acetic acid 
 
2.4.4 Solutions for electrotransfer and Western blot procedures 
 
Transfer buffer (TB) 
25 mM Tris (pH 8.3), 192 mM glycine, 0.1% (w/v) SDS, 15 % methanol 
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Tris Buffered Saline (TBS) 
50 mM Tris HCl, 150 mM NaCl, pH 7.3  
To obtain a blocking buffer for Western blot incubations, optionally add: 
0.05% Triton X-100 
2% bovine serum albumin 
 
Antibody stripping buffer  
100 mM 2-mercaptoethanol, 62.5 mM Tris-HCl (pH 6.8) 2% SDS, pH 6.7 (HCl-adjusted). 
 
2.4.5 Solutions for cardiomyocyte isolation and cell culture 
 
All solutions have to be sterile filtered or autoclaved (where possible). 
 
“Kraftbrühe” (KB) solution (according to Isenberg and Klöckner, 1982) 
70 mM KCl, 30 mM K2HPO4 , 3.96 mg/ml glucose, 1.22 mg/ml MgSO4 * 7H2O, 0.5 mM 
EGTA, 2.5 mg/ml taurine, 0.65 mg/ml creatine, 0.22 mg/ml pyruvic acid sodium salt, 10 mM 
succinate, 5 mM Na-ATP * 5H2O, 2 mM 2-hydroxy-butyric acid, pH 7.4 (adjusted with 
KOH), filter sterile. 
 
Joklik medium 
1 package of Joklik powder (Sigma-Aldrich) is dissolved in water and the following 
supplements are added: 30 mM taurine, 1 mM adenosine, 26 mM NaHCO3, 2.5 mM L-
glutamic acid.  The solution is stirred for 1 h under gassing (O2:CO2 mixture, 95:5%), pH 
adjusted to 7.1 (with NaOH or HCl), and the medium is then sterile filtered. 
 
Collagenase solution  
For one isolation procedure 120 units/ml collagenase type 2 (Worthington) are dissolved in 
50 ml Joklik medium for the perfusion solution and 60 units/ml in 20 ml KB solution. 
Collagenase solutions should be prepared before use because of autolysis of the enzyme.  
 
M199 – cell culture medium 
Medium was used supplemented with 20 mM creatine, 1% penicillin / streptomycin, 10 μM 
cytosine arabinoside, 10% fetal calf serum. 
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 2.5 Statistical analysis 
 
 Data were analysed using the Student’s t-test with p<0.05 as a criterion for statistical 
significance. Data were expressed as mean ± SEM (standard error of the mean), if not 
indicated otherwise. 
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3. RESULTS 
 
3.1 Cardiac and skeletal titin expression investigated by gel electrophoresis 
 
3.1.1 The ratio between cardiac titin isoforms is not significantly affected by titin 
degradation 
 
 Expression of the major titin isoforms (N2B and N2BA) in human myocardium was 
quantified by low percentage SDS-PAGE. Various acrylamide concentrations (1.8% to 2.8%) 
were used in agarose strengthened gels. 2.8% polyacrylamide gels separated MHC from titin 
and, with low resolution, cardiac titin isoforms, N2B and N2BA (Figure 13). The ratio 
between proteins appearing on gels was calculated from the calibrated OV of the bands. The 
results were presented either as the ratio between the OV of the bands or as a percentage like: 
       (4) 
 For an appropriate quantitation of the OV ratio of the bands, a calibration procedure 
was necessary, since the gel bands of different proteins could have different stainability: the 
porosity of the gel (determined by the polyacrylamide concentration) is a factor that 
influences the protein staining properties of the coomassie dye (Neuhoff et al., 1990). Hence, 
the data included in the statistics on protein expression ratio were usually obtained from the 
same gel type. Also, the range of protein loading on a gel lane within which the OV increases 
linearly is limited. Therefore, “calibration gels" were generated to measure the relationship 
between the amount of total protein loaded on lanes and the expression ratio for proteins. 
On 2.8% SDS-PAGE gels, protein load did not significantly affect the N2BA:N2B 
titin-isoform ratios, in the range from 20 to 70 µg per lane (Figure 13). Titin isoform ratios 
were similar to those determined on 2-10% polyacrylamide-gradient gels. The titin : MHC 
ratio on 2.8% gels was constant at loads >55 µg/lane (Figure 13) but was generally lower 
(≤0.1) than that seen on 2-10% polyacrylamide gradient gels (~0.21); the latter value has also 
been reported in the literature (Granzier and Irving, 1995; Liversage et al., 2001). The 
differences in the titin : MHC ratio thus arise from the usage of different gel types. No effort 
was made to further explore possible reasons for these differences. 
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Figure 13. SDS-PAGE calibration gels to determine the relationship between ratios of optical 
volume (band intensities) and protein loading. For titin, the N2BA proportion is relatively 
constant for a large range of protein loadings, whereas the apparent titin:MHC ratios are 
highly dependent on protein load (and gel concentration).  
 
Titin is well known to be rapidly cleaved by very low amounts of trypsin. Incubation 
of myofibrils with low-dose trypsin was reported to leave intact all other sarcomeric proteins 
except titin (Cazorla et al., 1999). An explanation for this effect may be the easy accessibility 
of the enzyme to degradation sites facilitated by the long extended shape of the titin 
molecule. Also, the number of cleavage sites may increase with the dimension of the 
polypeptide, which would explain the high susceptibility of titin molecules to trypsin 
compared with other proteins. In the case of titin, larger isoforms might be affected more 
rapidly by trypsin than shorter isoforms.  
A sign of titin degradation is considered to be the appearance of T2-bands (MW, 
2300-2500 kDa) on SDS-PAGE gels. We addressed the possibility that differences in 
measured titin isoform ratio arise from a different susceptibility of the isoforms to 
degradation (Figure 14). A normal human-heart sample was allowed to degrade at room 
temperature in the absence of leupeptin. The intensity of T2, the titin-degradation band, 
rapidly increased, whereas the N2BA:N2B ratio initially remained unaltered and was reduced 
only after 30 to 60 minutes of degradation. We conclude that under “normal“ study 
conditions (i.e., in the presence of leupeptin, which largely prevents appearance of T2), the 
measured N2BA:N2B ratio is independent of possible minor protein degradation processes. 
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Figure 14. Assessment of titin degradation. Tissue samples were left to degrade at room 
temperature in the absence of protease inhibitor (leupeptin). After 10 minutes, strong T2 
bands (titin degradation products) appeared and the intensity of the native titin bands 
decreased, without a significant change in N2BA:N2B ratio. Symbols are mean ± SEM (n=6). 
 
3.1.2 Multiple isoforms are visible within the N2BA-titin band 
 
The best separation of titin bands was obtained using 1.8% SDS-polyacrylamide gels 
(Figure 15). Typically, rabbit soleus muscle and normal rat heart showed a sharp band at 
3600-3700 (N2A isoform) and 3000 kDa (N2B isoform), respectively.  In contrast, a human 
heart sample exhibited both a sharp N2B band and a wide N2BA-titin band (3300-3500 kDa), 
suggesting the presence of multiple N2BA isoforms. 
 
Figure 15. 1.8% SDS-PAGE gel used to determine titin isoform expression in rabbit soleus, 
human heart and rat heart tissue. N2A and N2B titin were sharp bands, whereas N2BA-titin 
appeared as a spectrum of isoforms with various molecular weights from ~3300 to 3500 kDa. 
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To confirm the identity of the bands we employed Western blotting after running 2% 
SDS-PAGE titin gels. Antibodies to both N2B and N2BA titin were used. Staining of N2BA 
titin using MG1 antibody (to N2-A domain) was frequently stronger in CAD and DCM hearts 
than in normal hearts. Both isoforms were visualized by reprobing the same membranes with 
BD6 antibody (stains near the I-band/A-band junction) (see Neagoe et al., 2002). 
   
3.1.3 Co-expression of cardiac titin isoforms occurs at the sarcomere level 
 
Titin provides an elastic link between the Z-disc and the M-line of the sarcomere. A 
variable combination of functional modules in I-band titin (Ig domains, PEVK and N2B 
segments) gives rise to a large variety of muscle-specific titin isoforms. As mentioned above, 
cardiomyocytes co-express two major titin isoforms, N2B and N2BA, in the same sarcomere. 
Co-expression of different length titin isoforms in a sarcomere is a way to adjust myofibrillar 
passive stiffness (Linke et al., 1999). In the experiment of Figure 16, a human cardiac 
myofibril was stained with two different antibodies, to N2-B domain (N2B) and to N2-A 
domain (MG1). The MG1 antibody stained in a regular double-striated pattern showing the 
presence of N2BA titin in all sarcomeres. There were no myofibrils/sarcomeres detected that 
did not stain positive for the N2BA isoform (also see Neagoe et al., 2002). 
 
 
Figure 16. Titin expression in human cardiac myofibril by immunofluorescence microscopy 
using epitope-specific antibodies. Both N2B and N2BA titin are stained by N2B-antibody, 
whereas N2BA is stained only by MG1. The two epitopes co-localize in all sarcomeres and 
move together during stretching (myofibril mechanical manipulation by Dr. Michael Kulke). 
 
3.1.4 Analysis of titin isoform size and composition by gel electrophoresis  
 
Cardiac titin isoform ratio varies between species, following a trend in which small 
mammals like rats express almost exclusively N2B titin, whereas in the myocardium of cows 
 46
or pigs the N2BA-isoform predominates or is at least as abundant as the N2B-isoform 
(Cazorla et al., 2000). As the body weight of a mammal seems to correlate well with the heart 
rate (Lindstedt et al., 2002), there may also be a direct relationship with the cardiac titin 
isoform ratio. On the other hand, it was reported that titin isoform composition varies 
substantially in one and the same heart (Cazorla et al. 2000): the right atrium of pig and cow 
expresses relatively more N2BA than the left ventricle. Additional variation in N2BA:N2B-
titin ratio is seen between sub-epicardial, midwall, and sub-endocardial tissue. 
A systematic assessment of cardiac titin-isoform expression and composition was 
performed in several species using high resolution 2% SDS polyacrylamide gel 
electrophoresis (Figure 17). The main results of these studies were as follows: 
a) The MW of N2B cardiac-titin isoform was similar in all mammalian species 
investigated, around 3000 kDa. 
b) The molecular size of the adult N2BA-titin isoform(s) was between 3200 and 3400 
kDa, in agreement with the sizes expected from sequence analysis (3200-3350 kDa; Freiburg 
et al., 2000); these isoforms are likely to represent full length titin molecules. 
 
 
Figure 17. Cardiac titin isoforms in different species. Multiple N2BA-titin bands were 
identified in a MW range from 3.2 to 3.4 MDa. N2BA:N2B ratio varied considerable from 
almost exclusively N2B in rat heart up to ~70% N2BA in cow RV. The respective N2BA 
proportion (% of N2B + N2BA) is indicated above each lane (from Neagoe et al., 2003). 
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 c) The N2BA:N2B titin ratio varies considerably between species and is not strictly 
related to heart mass, heart rate or body size. The N2BA-titin percentage in the LV increased 
in the following order: rat < hamster < rabbit (not shown here) < mouse <sheep < human < 
cat < pig (not shown) < goat < cow. 
d) The N2BA : N2B titin ratio varies between the LV and the RV of the same animal 
(this comparison was made in hamster, rabbit, sheep, goat, and cow heart); RV was found to 
always have higher ratios than LV.  
e) In some species (e.g., rat, hamster) the cardiac N2BA-titin band appeared as a clear 
doublet, or even a triplet in pig RV (data not shown). The MW of the doublets was 3200-
3400 kDa in rat and hamster and 3400-3500 kDa in cow. The two N2BA bands were best 
detected when the gels were loaded with sufficient amount of protein and destained modestly. 
A doublet N2BA-titin band had been previously reported for bovine left atrium (Trombitas et 
al., 2001). 
f) There is some correlation between the resting heart rate of a mammalian species 
and the titin isoform ratio. However, some species do not fit in this trend, e.g. mouse has 
about 20% N2BA titin but a faster heart rate than rat, which has less than 10% N2BA titin. 
g) Frog ventricle expresses a single titin isoform of ~3300 kDa MW. Antibody 
staining suggested that some of the mammalian titin epitopes are present in frog heart titin, 
whereas others are missing. The identity of this frog cardiac titin band (N2B, N2BA, N2A or 
other) remains to be determined. 
h) T2-bands, considered to be proteolytic products of intact titin, were quite faint on 
these gels, indicating that the tissue preparation procedure resulted in only minor titin 
degradation and that the method used for quantitation of titin isoform ratio is reliable. 
 
The titin gel information was used to quantify the titin expression ratio in human heart 
samples. To do so, an intensity profile crossing the titin bands perpendicularly was recorded 
and parameterized using a three-Gaussian fit, where a one-Gaussian described the N2B peak 
and the sum of two Gaussians the broad N2BA signal (Figure 18). In Makarenko et al. (2004) 
and Opitz et al. (2004), the parameters obtained from such fits were used to predict titin-
based stiffness, by also considering the parameters of titin elasticity determined by single-
molecule mechanics (Li et al., 2002). 
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Figure 18. Average intensity profile (open circles) of cardiac titin bands separated on 2%-gel 
lanes (a typical lane is pictured as inset; profiles of from 7 human DCM were included in the 
analysis). Assuming that the band that represents a titin isoform appears on gel as a Gaussian 
distribution of the staining intensity, the experimental curve of the N2BA-titin band is fitted 
as a sum (thick line) of two Gaussians. A doublet N2BA-titin band is suggested (the 
mathematical fit was performed by Dr. Mark Leake). 
 
 
3.1.5 Topology of cardiac titin isoform composition in normal adult hearts 
 
 Previously it was reported that the N2BA:N2B isoform ratio differs in sub-epicardial 
tissue versus sub-endocardial tissue (Cazorla et al., 2000). This issue was studied in the 
cardiac walls of normal adult human, sheep, goat, rabbit and pig hearts. However, no 
significant transmural differences in the N2BA:N2B ratio were found, although in the hearts 
of larger species like goat there was a trend towards increased N2BA proportions in the 
endocardium, compared to the epicardium (Figure 19). In contrast, there was substantial 
heterogeneity of titin isoform composition across the heart chambers. The apex expressed 
relatively less N2BA titin than the heart basis (Table 1 and Figure 19). The interventricular 
septum showed an N2BA:N2B ratio in between that of the apex and basis. The RV had a 
higher N2BA percentage than the LV. 
Particular attention was paid to the situation in human left ventricle (non-failing donor 
hearts). The possibility of a transmural gradient in N2BA:N2B ratio was investigated using 
sub-endocardial, mid-wall, and sub-epicardial LV tissue from altogether 9 donor hearts 
(Figure 20). However, no transmural gradient of titin isoform ratio could be detected. 
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Figure 19. Topology of N2BA:N2B-titin isoform ratio in the heart of a goat. The right 
ventricle has a higher relative N2BA expression than the left ventricle. The N2BA:N2B ratio 
decreases from the basis to the apex. 
 
Table 1. Results of 2% SDS-PAGE analyses of goat heart tissue. Percentage of N2BA titin 
(relative to N2B+N2BA, which is 100%) is presented as mean ± SD (number of lanes analyzed). 
No/yes indicates whether there are statistically significant differences between the samples from 
different regions of the heart, at the p<0.05 level (unpaired Student’s t-test). LV: left ventricle; 
RV: right ventricle; Epi: sub-epicardium; Endo: sub-endocardium; mid: mid-wall. 
 
 LV, 
epi, 
basal 
LV, 
epi, 
equatorial 
LV, 
endo, 
equatorial
Septum, 
mid, 
equatorial
RV, 
epi, 
basal 
RV, 
epi, 
equatorial 
RV, 
endo, 
equatorial 
RV, 
epi, 
apical
Apex,
epi 
LV, epi, basal 61±2 (6)         
LV, epi, 
equatorial 
no 56±3 (5)        
LV, endo, 
equatorial 
no no 61±1 (4)       
Septum, mid, 
equat. 
no no yes 57±1 (4)      
RV, epi, 
basal 
yes yes no yes 74±4  
(5) 
    
RV, epi, 
equatorial 
no yes no yes yes 65±2 (8)    
RV, endo, 
equatorial 
yes yes yes yes no no 69±1 (6)   
RV, epi, 
apical 
no no no no yes yes yes 58±1 
(7) 
 
Apex, epi yes no yes no yes yes yes no 53±3  
(5) 
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Figure 20. N2BA:N2B titin ratio assessed in human LV across the ventricular wall in the 
medial plane. Titin isoform ratio did not vary significantly from the sub-epicardial to the sub-
endocardial region; the variation in N2BA-titin percentage was less than 5%. 
 
3.2 The N2BA:N2B isoform expression pattern is altered in diseased hearts 
 
 
3.2.1 Increased N2BA:N2B titin ratio in hearts of coronary artery disease patients 
 
Myocardial samples from human patients with coronary artery disease (CAD) were 
investigated for their titin isoform pattern, in comparison to non-ischemic transplants and 
non-failing human donor hearts.  The average N2BA proportion of individual HHs is shown 
in Table 2. Values in each group were then averaged (“mean of means”). The relative N2BA-
titin content in CAD-transplants was 47.0±2.4%—significantly higher (p<0.05) than in non-
ischemic transplants (32.1±1.4%), CAD donors (29.5±2.6%), and normal donors (28.1±0.8%) 
(Figure 21). All CAD-transplant hearts showed higher N2BA-titin expression than normal 
donor hearts. The total amount of titin (N2B+N2BA) was similar in all HH-groups (data not 
shown). Four non-ischemic transplant hearts were also analyzed and they showed a slight 
increase in average N2BA percentage compared to donor hearts, 34% ± 4% (Figure 21). 
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Table 2. Results of gel-electrophoretic titin analysis of individual HHs. Average relative 
N2BA-titin content (N2BA+N2B=100%) was measured from the optical volume of bands 
on coomassie-stained 2% SDS gels (n, number of lanes analyzed). Modifications of cTnI 
were studied on Western blots (10-20% polyacrylamide gradient gels), using TnI-antibody 
8I-7. Symbols indicate TnI-band intensity: (-) no; (±) faint; (+) normal; (++) strong band. 
(from Neagoe et al., 2002). 
 
Heart number age/ 
gender 
cTnI-degradation/ 
cTnI-complexes 
N2BA-titin (%),  
mean±SD (n) 
CAD Transplants 
    
HH1 
HH17 
HH22 
HH26 
HH27 
 52/M 
 65/M 
 45/M 
65/F 
55/F 
±/+ 
±/+ 
+/++ 
±/± 
+/± 
  53.3±3.5 (18) 
48.5±3.6 (7) 
39.4±2.3 (6) 
49.6±3.1 (5) 
44.3±3.7 (7) 
Non-ischemic Transplants 
  
HH3 
HH4 
HH12 
HH21 
 ?/F 
65/M  
?/F 
  ?/M 
-/- 
±/± 
-/± 
 +/- 
31.2±6.9 (6) 
  29.1±6.1 (12) 
 32.6±4.1 (10) 
35.7±3.8 (5) 
CAD Donors 
   
HH19 
HH30 
HH31 
HH33 
 56/M 
67/F 
 74/M 
 59/M 
+/+ 
-/± 
-/± 
±/± 
37.0±2.3 (7) 
25.7±4.6 (6) 
28.2±4.3 (6) 
27.1±5.6 (4) 
Normal Donors 
   
HH5 
HH6 
HH7 
HH9 
HH10 
HH15 
HH24 
HH25 
HH37 
HH38 
HH44 
HH46 
51/F 
43/M 
16/F 
56/M 
64/F 
23/M 
67/F 
54/F 
?/? 
?/? 
?/? 
?/? 
-/- 
±/± 
±/± 
-/- 
-/- 
-/- 
±/- 
±/+ 
-/- 
+/- 
±/- 
-/- 
25.3±3.9 (20) 
 28.1±2.7 (11) 
29.2±3.2 (5) 
22.7±4.1 (11) 
25.1±3.3 (8) 
29.7±3.2 (8) 
27.8±1.9 (7) 
30.9±3.5 (6) 
25.4±3.8 (7)  
  30.6±3.2 (11) 
  30.4±2.9 (10) 
  31.9±4.5 (11) 
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Figure 21. Titin isoform composition in human hearts. Titin band intensities were measured 
on coomassie-stained 2% SDS-polyacrylamide gels. (Left) Average N2BA + N2B 
percentage in the four different human heart groups investigated. The CAD transplant group 
showed more relative N2BA-titin content than any other group (* p<0.002 in Student’s t-
test). (Right) Histogram distribution of N2BA titin (% of N2B + N2BA) in HH groups. 
 
 
3.2.2  Broadening of the N2BA isoform spectrum in failing myocardium 
 
 Not only the N2BA:N2B isoform ratio was assessed in the human hearts, but also the 
broadness of the titin bands measured on 2% gels by generating an intensity profile and 
determining the full width at half maximum (FWHM) of the respective peaks (Figure 22). 
The N2BA band of failing HH samples (LV from dilated cardiomyopathy (DCM) and CAD 
hearts) was much broader than the N2BA band of normal HHs (Figure 23). In contrast, the 
N2B-titin band was of similar sharpness in all HH groups. Further, the distance between the 
centers of mass of the N2B and N2BA peaks was increased in the failing myocardium, 
demonstrating the increased expression of larger N2BA isoforms. Simulating the intensity 
profiles as Gaussian distributions again suggested that the N2BA titin is the sum of two 
closely spaced bands, as the intensity profile could be best fitted by two Gaussian curves (see 
Figure 18). Thus, human myocardium contains at least two distinct species of N2BA isoform. 
However, owing to the estimated resolution limit of ~80 kDa in the titin size range, it cannot 
be excluded that HH expresses a multitude of N2BA-titin isoforms.  
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 Figure 22. Image of a 2% gel discerning titin isoforms. The N2BA– titin band is broader for 
the failing heart (here DCM) samples and is shifted towards higher molecular weights. 
(Right) Intensity profiles (8-bit greyscale) of normal HH and DCM HH lanes.  
 
 
Figure 23. Summary of the titin band FWHM signals. The number of HHs analyzed per 
group is indicated above the columns. The sharpness of the N2B band was unchanged (for 
extensive analysis see Makarenko et al., 2004), but the N2BA band was significantly 
narrower in normal donor than in failing HH samples (p<0.05). 
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3.3  Troponin I analysis 
 
A characteristic that discriminated CAD from DCM or normal donor HHs samples 
was the presence of ischemia. Even if necrosis is of limited extent in MI, cardiomyopathic 
processes can nevertheless impair the contractility of the non-infarcted cardiac tissue. A good 
biomarker for an acute ischemic event (in conjunction with reperfusion injury) was suggested 
to be the elevated serum concentration of cardiac TnI. Moreover, cTnI was proposed to be a 
potential predictor of increased risk for progressive ventricular dysfunction and congestive 
heart failure (Horwich et al., 2003). In the stunned myocardium cTnI undergoes typical 
modifications, as shown when ischemia was induced in excised rat hearts (McDonough et al., 
1999). Interestingly, also increased preload can lead to cTnI degradation (Feng et al., 2001). 
In this context, I tested whether ischemia produced cTnI modification in non-necrotic regions 
of CAD HH and whether this was related to changes in titin isoform ratio. 
Cardiac TnI modification was assessed by Western blotting (Figure 24). cTnI 
degradation as well as formation of complexes containing cTnI were detectable when normal 
HH sample was purposely left to degrade for 1 h at 25°C in the absence of protease inhibitor, 
leupeptin. Similar alterations to cTnI were seen in CAD HH. Table 2 summarizes the types of 
cTnI modification seen. In CAD cTnI was more strongly modified than in normal donor HH.  
These changes appeared to correlate with the degree of changes in titin isoform expression. 
 
Figure 24. Cardiac troponin I modifications assessed by Western blot (8I-7 antibody). (first 
two lanes) A normal cardiac (HH5) sample degraded for 1h in absence of leupeptin revealed 
cross-linking (c) and proteolysis of cTnI (d). (Other lanes) Compared to normal HH, CAD 
HHs showed substantial cTnI modification. The modified cTnI was similarly present in the 
“pellet” and “supernatant” fractions, but only the “supernatant” data are reported.  
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3.4 Structural changes to the myocardium - in situ detection of titin, collagen and desmin 
 
Mechanical overloading often leads to cardiac remodelling, among others affecting 
the connective tissue, e.g., increasing the collagen content. It was therefore of interest to 
study in sections of HH tissue (CAD versus donor) the expression of titin along with possible 
changes in collagen expression. A change in titin isoform pattern could potentially be caused 
by one or a combination of the following:   
a)  A loss of titin affecting preferentially the stiff titin isoform, N2B;  
b) Upregulation of total titin favouring the N2BA isoform;   
c) A true switch of isoforms, where N2BA partially replaces the N2B.  
Further, titin changes could occur uniformly in large areas of the heart or affect only 
some cells or myofibrils and leave others unaffected. To test for this possibility, 
paraformaldehyde-fixed tissue sections were incubated with titin antibodies of known epitope 
specificity (also see Freiburg et al., 2000). Fluorescence microscopy showed a regular striated 
pattern using an antibody directed against the N2A-domain (MG1), with the fluorescence 
intensity being similar in diseased (CAD) and control (donor) HH samples (Figure 25 A). 
Similarly, with antibodies to both titin isoforms (N2B and BD6), the staining was comparable 
between diseased and control tissue (see Neagoe et al., 2002, Figures 4B and 4C). 
Figure 25. Immunofluorescence microscopy on cardiac muscle sections. (A) Titin staining is 
regular in normal and CAD samples. (B) Collagen-1 staining around cells is stronger in CAD 
than in normal HH. Inset: collagen signals after 6x increased primary antibody concentration. 
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 Expression of collagen type I was upregulated in CAD, whereas in normal donor heart 
collagen staining was generally of low intensity (Figure 25 B). Thus, in CAD hearts the total 
amount of titin seemed unchanged and the titin isoform switch towards N2BA likely occurred 
uniformly in large groups of myocytes. In no case could one observe in the diseased 
myocardium irregularities of the myofibrillar staining for titin. Enlarged extracellular space 
and misalignment of the fibers were more often found in samples from failing myocardium. 
 
The intermediate filament protein, desmin, also has a mechanical function in cardiac 
myocytes, as it interconnects parallel sarcomeres at the Z-discs. The myofibrillar localization 
of desmin was assessed on normal and CAD samples by immunofluorescence microscopy.  
Desmin was present at the Z-discs and absent in the A-bands or I-bands of the sarcomeres, 
but its distribution was unchanged in CAD versus donor samples.  However, the fluorescence 
intensity was clearly increased in CAD myofibrils, indicating upregulation of desmin 
expression (Neagoe et al., 2002). 
 
3.5. Mechanical characteristics of human heart myofibrils 
 
3.5.1 Structural preservation of myofibrils isolated from frozen human heart tissue 
 
Titin and collagen are the two major contributors to passive stiffness in myocardium. 
The stiffness of the non-activated sarcomeres is generated essentially by titin (Linke et al. 
1994), whereas collagen is principally responsible for the stiffness of the extracellular matrix. 
To test for functional consequences of altered titin isoform expression, isolated myofibrils 
were prepared from frozen HH tissue, with the aim to measure their passive stiffness. As this 
was the first time that single myofibrils from frozen human heart were used for mechanical 
analysis, a number of control experiments were performed to test for the structural 
preservation of the specimens.  Titin was stained using antibodies to the N2A-domain (MG1) 
and the epitope spacing was measured in stretched HH myofibrils (Figure 26). The epitope 
spacing across the Z-disc increased with SL, proving the integrity of titin anchorage at the Z-
disc and the thick filament. The distance from the epitope to the Z-line at a given SL was not 
distinguishable between diseased and normal HH myofibrils, and it was comparable with 
published data obtained for rabbit cardiac myofibrils (Linke et al., 1999). 
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Figure 26. Assessment of the MG1 epitope displacement by stretch demonstrated that in 
specimens from frozen tissue titin is anchored in the Z-disk and attached to the thick filament. 
 
Another control was to test whether myofibrillar passive stiffness can principally be 
influenced by sample storage at –80°C. Passive stiffness was therefore measured in 
myofibrils from frozen or freshly dissected rat LV. No significant difference was noted (data 
not shown) and it was thus concluded that deep-freezing does not alter the passive 
mechanical properties of the myofibrils. 
 
 
3.5.2  Myofibrillar passive stiffness: correlation to N2BA-titin proportion  
 
Force measurements were done to estimate the passive length-tension curves of 
nonactivated HH myofibrils. Cardiac myofibrils with elevated N2BA-titin content were 
isolated from HH1 and HH17 (CAD group) as well as HH2 and HH8 (DCM group). Normal 
myofibrils were obtained from HH6 and HH10. All myofibrils presented a regular sarcomeric 
pattern and their slack SL was close to 1.85 µm.  
Myofibrils of diseased hearts responded to stretch with lower forces than normal HH 
myofibrils (Figure 27). Differences between passive tension generated by normal myofibrils 
and CAD myofibrils were significant (p<0.05, Student’s t-test) at SLs equal to or longer than 
2.1 µm. These mechanical changes correlated well with the increased proportions of 
compliant N2BA titin isoform in CAD samples. Although the CAD myofibrils showed 
reduced passive stiffness, the CAD hearts were globally stiffened, as judged by the increased 
LV end-diastolic pressure (LVEDP) (Figure 28). These results suggest that titin-based 
stiffness is decreased in CAD hearts due to titin-isoform switch, but these changes are more 
than compensated for by increased collagen stiffness.  
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Figure 27. Force measurements on isolated myofibrils from normal and CAD-transplant HH. 
The specimen was stretched stepwise (SL indicated on top of the force traces), then released 
to the initial length. 
 
            
 
Figure 28. Passive stiffness comparison of CAD versus donor HH samples. (Left) Average 
quasi-steady-state passive tension at different SLs (100% is the average force at SL = 2.4 μm) 
for normal and CAD-transplant HH myofibrils. In the interval from 2.1 to 2.4 μm SL, the 
differences between normal and CAD myofibrils are statistically significant. n, number of 
myofibrils stretched. (Right) Whole hearts of CAD-transplant showed increased LVEDP 
compared with the normal range of LVEDP in healthy hearts.  
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 3.6 Titin isoform switching in an experimental model of infarcted rat heart 
 
To test whether ischemic conditions result in a titin isoform shift in an experimental 
model of heart failure, RV tissue from rats with a ligation of the left anterior descending 
coronary artery (LAD) (Daniels et al., 2001) were examined for expression of cardiac titin. 
Non-necrotic tissue was probed for titin on silver-stained titin gels (Figure 29). In all samples 
a strong N2B titin band was detectable, but in LAD samples there was an increased frequency 
of an N2BA isoform band appearing above the N2B band. Immunoblot analysis confirmed 
the identity of the detected titin bands as N2BA and N2B (Figure 29). In LAD rat RV a 
double titin band was observed in 43% of all samples, in control (sham-operated) RV only in 
14%. Results were similar in RVs 12 and 24 weeks after surgery.  
 
 
Figure 29. Detection of N2BA-titin in rat myocardium. An N2BA-band sometimes appeared 
as a distinct peak in the intensity profile plot at the position of N2BA-titin MW. The identity 
of those bands was determined by Western blot. The frequency of the N2BA band 
appearance was higher in LAD rat hearts than in sham-operated hearts.  
 
 
To determine whether the total amount of titin is changed or whether one titin isoform 
is partially replaced by another, the titin (N2B+N2BA) to MHC ratios were determined in the 
rat samples. Although the LAD hearts showed significant LV hypertrophy, no alterations in 
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titin:MHC ratio were detected (Figure 30), suggesting the total titin remained unchanged.  
However, titin content decreased with age in both LAD and SHAM hearts (Figure 30).  
 
 
 
 
Figure 30. Titin protein content in rat cardiac right ventricle. (Top diagram) 2.8% SDS-
PAGE revealed similar titin-to-MHC ratios in LAD and sham-operated specimens (n=8 per 
column). (Bottom diagram) On silver-stained 2% SDS gels, total cardiac titin content was 
decreased with age in a statistically significant manner (p<0.05 in Student’s t-test) but was 
similar in LAD and sham-operated animals both 12 and 24 weeks after surgery (n=8 per 
column). Numbers above diagrams indicate cardiac hypertrophy in LAD (Wt, weight). 
 
 
3.7 Contribution of the elastic energy to the active contraction of sarcomeres 
 
 Recently it was demonstrated that titin conserves the stretch energy in a sarcomere 
and releases part of it to support muscle contraction (Minajeva et al., 2002). Previous work 
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suggested that the unloaded shortening velocity of a skeletal muscle increases once the 
muscle length exceeds a certain value (Edman, 1979). Minajeva et al (2002) showed that the 
passive recoil of titin in myofibrils is fast, initially reaching velocities an order of magnitude 
higher than the maximum active shortening speed. Titin’s contribution to shortening of rabbit 
psoas sarcomeres was estimated to be 10% of the contribution from active elements, if the 
precedent stretch was below 0.7 μm per sarcomere. Up to these stretch amplitudes, the 
maximum unloaded shortening velocity was nearly constant (Figure 31). At higher sarcomere 
stretches and therefore higher passive tension, the maximum unloaded shortening velocity of 
fully activated psoas fibers was significantly increased (Figure 31), likely owing to the 
contribution of titin elastic recoil to the shortening speed.  
 
 
Figure 31. Maximum unloaded shortening velocity of sarcomeres (V0) in fully activated 
(pCa 4.5) skinned rabbit psoas fibers. A “slack test” was performed according to Edman 
(1979). V0 was constant over a large range of SL, but at high stretch it increased steeply 
(from Minajeva et al., 2002). 
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4. DISCUSSION 
 
4.1 Cardiac and skeletal muscle titins can be detected on low porosity SDS-PAGE gels 
 
Titin is encoded by a single gene containing 363 exons in humans. Owing to 
alternative splicing two major cardiac isoforms are generated, the shorter and stiffer N2B and 
the longer, more compliant N2BA (Freiburg et al. 2000). Skeletal muscles express the N2A 
titin isoforms in a muscle-specific manner (Prado et al., 2005). Alteration in titin isoform 
expression in cardiac muscle leads to a modulation of the titin-based passive tension in 
chronically diseased hearts (Neagoe et al., 2002). Recently it was demonstrated that cardiac 
N2BA titin is expressed in various fetal and neonatal isoforms which later disappear in the 
adult organism, being largely replaced by the N2B isoform (Opitz et al., 2004; Lahmers et al., 
2004). How the translation of a giant protein like titin is accomplished in muscle cells is still 
unknown but it likely requires a precise regulatory machinery perhaps promoting co-
translation of titin along with major titin-associated proteins like muscle myosin or alpha-
actinin. Titin may be a template for proper muscle assembly and therefore required for 
normal muscle function. 
 
The initial interest in titin came from its postulated contribution to the passive 
elasticity of striated muscle. Although several titin isoforms were known to exist in human 
and other mammalian heart muscles, routine isoform analysis was hampered by the giant size 
of this protein, which required very loose gels to be prepared. This thesis was aimed at 
detecting titin isoforms on high resolution 2% SDS-PAGE titin gels, an approach that had not 
been attempted previously for human heart samples. I found that titin isoforms can indeed be 
visualized by gel electrophoresis as multiple bands in the megadalton range. Some of these 
bands corresponding to the intact, full-length, titin molecule were named T1- titin bands, 
whereas proteolytic degradation products also appearing on the gels were named T2 and T3 
titin bands. I observed that titin degradation products, when they exist, are clearly 
distinguishable on the gels from the intact titin bands (Figure 14) and that modest degradation 
does not significantly affect the T1 cardiac isoform ratio; the isoforms are equally degraded. 
This analysis was important, as it allowed a major conclusion to be drawn from my results: 
the observed titin isoform switch in diseased human hearts is unrelated to titin degradation. 
This work led up to the first publication on titin isoform analysis in normal and failing (CAD) 
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human heart (Neagoe et al., 2002), advancing earlier work on cardiac titin expression in other 
mammalian species (Trombitas et al., 2001; Wu et al 2002).  
 
Another in-depth report on cardiac titin isoform composition and related functional 
aspects was published later (Makarenko et al., 2004), focusing on human DCM (non-
ischemic) heart. Evidence provided by 2% SDS-PAGE demonstrated that failing DCM hearts 
displayed an asymmetric broadening of the N2BA band compared with normal donor HH, 
indicating a true shift towards increased expression levels of very high-molecular weight 
N2BA titin isoforms. Similar findings for DCM samples were reported by Nagueh et al. 
(2004). These authors also showed a correlation between the extent of the N2BA:N2B titin 
switch and the severity of the DCM disease state. Yet another study on titin expression in a 
larger collection of different vertebrate species showed a great variety of titin isoform 
patterns in different cardiac and skeletal muscles (Neagoe et al., 2003). This work was 
followed by a study on cardiac titin isoforms in perinatal rat heart development (Opitz et al., 
2004), which established the presence of at least four distinct cardiac N2BA-titin isoforms in 
the course of late embryonic and early postnatal development. The molecular mass of these 
titins switched from 3700 kDa (N2BA-1) to 3500-3600 kDa (N2BA-2) in the fetus and 
newborn to 3200 (N2BA-3) and 3400 kDa (N2BA-4) in the adult, the latter isoforms being 
co-expressed with the predominant N2B titin (3000 kDa). Importantly, in the above 
experiments the titin:MHC remained unaltered suggesting that the total titin in a sarcomeres 
may be a rather constant value. This is consistent with models of myofibrillar architecture 
that do not support a variable stoichiometry between titin and myosin (Liversage et al., 2001). 
 
What could be the reason for the presence of multiple titin isoforms in different 
muscles or even in the same myofibril and the dramatic isoform switching in development 
and heart disease? Presumably, the expression of different length titin isoforms in different 
muscle tissues is a way to adapt passive tension to particular functional (mechanical) needs 
(Wang et al., 1991). In this context it may be relevant that myocardium expresses N2BA:N2B 
ratios that show some correlation to the body and heart size of the respective species (Cazorla 
et al., 2000; Neagoe et al., 2003; Granzier and Labeit, 2002). Why would the hearts of small 
animals preferentially express the stiff N2B-titin? One can imagine that a mechanical 
oscillator that has a stiff spring has a higher resonant frequency. For instance, Drosophila 
indirect flight muscles (IFM) expresses a titin homologue named kettin, which is a 
comparably short and stiff elastic protein (Kulke et al. 2001 a). Kettin's high stiffness is 
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necessary for the high frequency working regime of the IFM that drives the wingbeat. 
Similarly, the low cardiac N2BA:N2B titin isoform ratio in small mammals like rat, mouse or 
hamster, compared to large mammals like cow, pig or goat, will cause the myofibrils in heart 
to be relatively stiffer in the former than in the latter. This may be beneficial as the small 
rodents have a higher heart rate than the large mammals. The higher the heart rate, the greater 
may be the mechanical stability of the ventricular walls required. However, titin is only one 
factor contributing to passive stiffness in diastole, as other factors also play a role, such as 
chamber geometry, ventricular wall thickness, and extracellular matrix proteins (collagen). 
Nevertheless, titin isoform composition and titin stiffness may be critically important. 
 
 It was also proposed that regional differences in titin expression pattern in heart, 
particularly transmural differences in N2BA:N2B titin ratio, are disturbed under disease 
conditions, as e.g. follow from chronic pacing (Bell et al. 2000). I analyzed the transmural 
distribution of the N2BA:N2B ratio but did not detect differences in normal goat heart 
(Figure 19), non-failing human donor heart (Figure 20), and also in normal sheep, pig and 
cow heart (data not shown). If they existed at all, transmural differences in titin composition 
may indeed be small in normal heart, but may be exaggerated in diseased heart (Bell et al., 
2000; Wu et al., 2002). In Neagoe et al. (2003) I showed instead that normal heart expresses 
quite different N2BA:N2B ratios in the different cardiac chambers, as well as at the base 
compared to the heart’s apex.  
 
 The signaling pathways causing the titin isoform switch have only very recently been 
investigated. A recent paper (Krüger et al. 2008) described experiments on developing rat 
cardiomyocytes in culture exhibiting a titin switch similar to that in rat heart tissue in vivo. It 
was found that a main trigger for the titin switching is an activation of the phosphoinositol-3-
kinase (PI3K) and Akt (protein kinase B) pathways, e.g. by thyroid hormone, triiodo-L-
thyronine (T3). Whether deactivation of the PI3K/Akt pathway accounts for the reverse titin 
isoform switching in human heart disease remains to be shown.  
 
4.2 Collagen and titin: interplay between matrix and myocyte passive stiffness 
  
 Chronically diseased human CAD hearts expressed higher relative amounts of 
compliant N2BA-titin causing decreased myofibrillar passive stiffness (Neagoe et al., 2002). 
The total concentration of titin (titin:MHC ratio) was not different in diseased and normal 
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hearts. The titin isoform switch was really a switch of titin in myofibrils, as two different 
solubilization procedures, a whole tissue homogenate solubilization and a myofibrillar 
fraction solubilization resulted in the same titin isoform ratio for a given HH sample (data not 
shown). Initially it was surprising (or at least counter-intuitive) that the titin changes were in 
the opposite direction of what was expected from the observed global stiffening of the CAD 
hearts (increased LVEDP; although this does not necessarily mean higher myocardial 
stiffness). It was therefore speculated that the switch towards increased N2BA titin in failing 
myocardium is compensatory. As the titin-isoform switching was not the cause of the global 
stiffening in failing hearts, efforts were undertaken to investigate other determinants of 
passive stiffness, particularly the intermediate filament protein, desmin, and the collagen (I 
and III) expression levels. Collagen forms a stiff filamentous network around the muscle cells 
which limits the extensibility of the heart tissue (Weber, 1997). As for desmin, it was found 
that expression of this protein in heart is higher in cardiomyopathy than under normal 
conditions (see Hein et al., 2000, for a review). I could confirm by immunofluorescence 
microscopy that more desmin is present in the Z-disc of CAD myofibrils. Desmin contributes 
somewhat to myocyte passive stiffness and elevated desmin may be expected to increase the 
lateral stiffness and/or resistance to shear stress. However, isolated myofibrils from CAD 
hearts showed reduced passive stiffness despite upregulation of desmin. Expression changes 
of desmin could thus not explain the mechanical alterations.  
 
In contrast, collagen I was upregulated in CAD heart tissue and likely accounted for 
the increased global stiffness. Hence, a working hypothesis was proposed by Neagoe et al. 
(2002) suggesting that the titin changes towards compliant N2BA isoform may occur in 
response to the chronically increased extracellular matrix stiffness, compensating the latter to 
some degree: increased collagen elevates passive stiffness, whereas increased compliant titin 
lowers it. Whether the titin changes are a cause or rather a consequence of the remodelling in 
heart failure remains to be established. Clear is that an interplay between collagen and titin is 
important to tune myocardial passive stiffness.  
 
The titin isoform switch may occur over a relatively long time period, although the 
titin turnover (at least in developing heart) can be rather rapid, a few days (Opitz et al., 2004). 
In a rat model of myocardial infarction (LAD ligature) the number of LAD hearts showing 
upregulated N2BA titin was not much different 12 weeks following LAD surgery than 24 
weeks following surgery. In general the titin changes seen in the rat model were mild 
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compared those seen in human heart failure. This finding could be related to the fact that the 
LAD model does not closely mimic the chronic ischemia-induced CAD in humans. 
Revascularization and natural bypasses around the ligated artery are presumed to compensate 
the induced dysfunction in rat but such arterial remodelling may not occur in human disease. 
In any case, the studies on the LAD model of myocardial infarction demonstrated that it is 
possible to induce a titin isoform shift. However, the time course of the titin isoform 
switching remains to be established. 
 
4.3 Consequences of titin isoform switching for myocyte mechanical function 
 
Altered passive stiffness.  Previous studies on skeletal muscles showed a correlation between 
titin-isoform size and passive tension at the single-fiber level (Wang et al., 1991; Horowits, 
1992; Freiburg et al., 2000) and the single-myofibril level (Linke et al., 1996; Linke, 2000; 
Kulke et al., 2001 b). Differences in passive tension between cardiac, psoas and soleus 
myofibrils of rabbit were demonstrated by Neagoe et al. (2003). The two types of skeletal 
myofibrils studied showed a relatively long initial range of low passive tension, before the 
curves began to increase more steeply. This was interesting in light of early reports 
describing two distinct phases of passive-tension development in whole skeletal muscle – a 
low force, nearly linear phase followed by a highly nonlinear rise in force (Roy, 1881; 
Haycraft, 1904). Apparently, these passive-tension characteristics can be found also at the 
level of the single myofibril. Relatively lower passive tension was seen in soleus myofibrils 
expressing 3700 kDa titin N2A isoform than in psoas myofibrils expressing 3300–3400 kDa 
N2A titin (Neagoe et al., 2003). Thus, skeletal muscles can achieve lower or higher 
myofibrillar stiffness by expressing longer or shorter I-band-titin, respectively. The number 
of titin molecules in a sarcomere (which could also affect stiffness) is unlikely to vary 
greatly, due to stoichiometric constraints; there is evidence that the number of titin molecules 
per half thick filament is six (Liversage et al., 2001; Knupp et al., 2002). Compared to 
skeletal myofibrils, passive tension was much higher at any given SL in myofibrils from 
rabbit LV (Neagoe et al., 2003) and a somewhat shallower passive SL tension curve was 
found in myofibrils from human LV. This result correlates well with the differences in 
N2BA:N2B titin-isoform ratio, ~17:83 in rabbit LV, but ~30:70 in normal human LV 
(Neagoe et al., 2003). In summary, titin-isoform switching is a way to adjust titin-based 
myocyte stiffness in both cardiac and skeletal muscle.  
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Altered restoring forces and A-band centering properties. It was proposed that titin accounts 
in part for the forces that restore the length of the sarcomere after contraction (shortening) 
(Helmes et al., 1996). Titin also helps center the A-band in the sarcomere. A stiff titin should 
generate sufficient restoring forces and reset A-band central location in the sarcomere during 
diastole (Wu et al., 2000). A switch towards more compliant titin, as seen in heart failure, 
could compromise these functions of titin. The titin modifications could thus alter diastolic as 
well as systolic mechanical properties. 
 
Altered active force generation via effects on the Frank-Starling mechanism. Titin was 
proposed to play a role as a "length sensor" responsible for stretch induced Ca2+ sensitization 
of force, or length-dependent activation (LDA), the molecular basis for the Frank Starling 
mechanism of the heart (Fukuda et al., 2001; Cazorla et al., 2001). Titin could affect the 
lateral myofilament spacing by generating a force perpendicular to the myofibrillar axis 
(Cazorla et al., 2001).  A narrower spacing, as seen after sarcomere stretch, would allow 
myosin crossbridges to interact with actin more efficiently, which would increase the Ca2+-
sensitivity. Sarcomeric passive tension levels and calcium sensitivity were indeed correlated 
and titin was proposed to be important for this effect (Fukuda et al., 2001; Cazorla et al., 
2001). Titin isoform shift towards N2BA may affect LDA by lowering the lateral 
compressive forces and thereby be detrimental for the Frank Starling mechanism. 
 
Altered viscoelasticity via effects on titin’s actin-binding properties. Our group and others 
reported that titin interacts with actin filaments in the PEVK region and that this (weak) 
interaction generates an internal viscous load (Kulke et al., 2001 b; Yamasaki et al., 2001). 
Interactions between titin and actin filaments towards the free end of the thin filaments were 
also suggested to stabilize the sarcomeric architecture (Eremia, 2001). Passive shortening of 
the stretched sarcomeres arises from titin elastic recoil but viscous damping of the titin recoil 
probably originates in PEVK-actin interactions (Minajeva et al., 2002). The titin–actin 
interaction via the PEVK-region is likely to be dependent on titin-isoform expression. The 
length and the predicted isoelectric point of the PEVK-domain differ much between the N2B 
and N2BA titins (Greaser et al., 2001; Greaser et al., 2002). Thus, variable PEVK length may 
be a source of variability in internal viscous loading. Increased viscous drag in myocytes 
expressing relatively more of the long N2BA isoforms could affect the myofilament sliding 
speed in failing hearts, thereby reducing contractility. 
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4.4 TnI modification – a sign of increased preload or chronic ischemia? 
 
For most CAD hearts, the LVEDP was not available. To compensate, an indirect 
method of assessment was developed based on the assumption that cTnI modifications 
apparent on Western blots of failing heart tissue could be a marker for the degree of 
ischemic-reperfusion damage (McDonough et al., 1999). Another report later suggested that 
cTnI modification may be a sign of chronically increased preload, instead of ischemia (Feng 
et al., 2001). The latter was reason for us to study cTnI proteolysis and complex formation 
(cTnI covalently bound to other troponin isoform fragments; McDonough et al. 1999) in the 
human CAD samples along with the changes in titin isoform composition. Indeed, the CAD 
transplant samples showed, on average, greater cTnI modifications than normal donor human 
hearts. Whether these alterations were causally related to changes in titin composition or were 
merely coincidental could not be assessed. If the increased TnI modification in human heart 
failure indeed indicated chronically increased preload, the titin changes could be caused by 
overloading the heart in diastole. This interesting possibility could be investigated in the 
future, e.g. using cell culture systems where preload and ischemia can be manipulated 
independently. 
  
4.5 Perspective: Establishing a cell culture model system to study cardiac titin isoforms 
 Invited by Prof. Dr. Hans Eppenberger from the Institute of Cell Biology at the ETH 
Zurich (Switzerland), I had the opportunity to examine titin isoform expression in adult rat 
cardiomyocytes in long term cell culture. These experiments were thought as a first step 
towards establishing a cell culture model in which one could study the signaling pathways 
underlying the titin isoform switch in heart development and disease. The cardiac cells were 
derived from adult rat heart tissue and when cultured long-term, they expressed N2BA and 
N2B titin isoforms as demonstrated by immunofluorescence microscopy (data not shown). 
MG1 antibody to the N2A-domain displayed a doublet band around the Z-disc once the 
sarcomeres were stretched. These experiments paved the way for a systematic, extensive 
study of titin isoform switching in cultured developing rat cardiomyocytes, which established 
a central role of the PI3K/Akt signaling pathway for the titin isoform transition (Krüger et al., 
2008). 
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4.6 Conclusions 
 
 The main conclusions from this work are as follows: 
 
1) Cardiac muscles express various titin isoforms; the ratio between N2BA titin and 
N2B titin is species-specific; 
2) The ratio between N2BA and N2B titin is ~30:70 in normal human heart, but can 
increase to nearly 50:50 in hearts from end-stage CAD patients; 
3) Widening of the N2BA-titin isoform expression spectra is often found in end-stage 
CAD and DCM hearts, where longer-than-normal N2BA–titins are expressed; 
4) The titin isoform switching in human heart lowers sarcomeric passive stiffness; 
5) Although titin-based stiffness is decreased in failing human hearts, these hearts are 
globally stiffened due to increased fibrosis;  
 6) The titin modifications might partially counteract the elevated stiffness due to 
increased collagen expression; 
 7) Higher than normal or unchanged N2BA:N2B titin ratios may be found under 
different disease conditions; 
8) Further studies are necessary to characterize the signals that determine the disease-
related changes in cardiac titin isoform composition.   
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5. SUMMARY 
 
Background: Titin is a giant elastic protein of muscle sarcomeres. Titin molecules 
link the Z-disk with the M-line and have structural, elastic and signaling functions in 
myocytes. The primary structure determination of several titin isoforms and the mechanical 
characterization of different muscle tissues revealed that titin elasticity depends on the 
differential splicing of the titin spring region consisting of immunoglobulin-like domains, a 
so-called PEVK domain and larger unique sequence insertions like N2-B. The molecular 
weight of a titin isoform is correlated with its mechanical, spring-like properties: the smaller 
the isoform, the stiffer the spring. Heart muscles of mammalian organisms co-express two 
major classes of titin isoforms: the stiff N2B-titin and the compliant N2BA-titin. Sarcomeric 
stiffness is tuned by altering the expression ratio of N2BA:N2B titins, whereas the amount of 
total titin in a sarcomere likely is constant owing to stoichiometric constraints. 
Objectives of the study: 1) To determine the patterns of titin isoform expression in 
different muscle tissues using MDa-range high-resolution gel electrophoresis and Western 
blotting; 2) To understand the functional significance of the expression of various cardiac 
titin isoforms; 3) To look for variations in cardiac titin expression in diseased myocardium; 4) 
To establish conditions/factors determining different expression patterns of cardiac titin; 5) 
To understand consequences of pathological changes in titin protein expression for the heart.  
Methods and Results: N2BA to N2B titin isoform ratio was determined by loose-gel 
electrophoresis. The titin isoform ratio differed between: 1) Hearts from different mammalian 
species; 2) Various regions of the same heart; 3) Diseased and normal human hearts. Western 
blotting using sequence assigned anti-titin antibodies confirmed the identity of the titin bands. 
The N2BA proportion varied from ~5% in rat left ventricle to almost 70% in cow right 
ventricle. The N2BA:N2B ratio was generally higher in the right ventricle than in the 
corresponding plane of the left ventricle and decreased from the base to the apex of a given 
heart (assessed in goat and rabbit). Titin isoform expression was altered under disease 
conditions: human heart transplants due to coronary artery disease (CAD) exhibited an 
average N2BA:N2B ratio of 47:53, whereas normal donor hearts had a ratio of ~30:70. 
Increased expression of larger N2BA titin isoforms was also seen in failing myocardium of 
dilated cardiomyopathy (DCM) patients.  
Coexpression of N2BA-titin and N2B-titin in a sarcomere was demonstrated by 
immunofluorescence microscopy.  A regular cross-striated staining pattern for titin on tissue 
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sections of CAD-transplant hearts indicated uniform changes of titin expression instead of 
titin structural damage. The functional relevance of the observed changes in titin isoform 
expression was estimated in mechanical experiments on isolated myofibrils from human 
hearts. Diseased (CAD, DCM) human myofibrils expressing elevated N2BA proportions had 
lowered passive stiffness compared to non-failing human myofibrils. Thus, sarcomeres can 
modify their passive tension by adjusting the N2BA:N2B titin expression ratio. Failing 
human hearts, even if they are globally stiffened (collagen upregulated), have more compliant 
myofibrils than normal donor human hearts. 
Titin isoform switching was also studied in a rat model of myocardial infarction 
(ligature of left anterior descending coronary artery). Titin gels showed that 43% of diseased 
hearts displayed a distinct N2BA-titin band, compared to only 14% of the hearts of sham-
operated control rats, suggesting an isoform switch had occurred in this heart failure model.  
Conclusions: An improved titin detection method by modified 2% SDS-
polyacrylamide gel electrophoresis revealed the presence of multiple titin isoforms in 
different tissues. Results established that the elastic diversity of titin is altered in human heart 
disease and during development. The shift towards expression of more compliant titin 
isoforms in human heart failure alters mechanical properties of the cardiomyocytes, in 
particular the passive stiffness. The disease-induced shift in titin isoform ratio may also 
impair active contraction, e.g. by interfering with the ability of the heart to use the Frank-
Starling mechanism. 
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ZUSAMMENFASSUNG 
 
Hintergrund: Titin ist ein riesiges elastisches Protein der Muskelsarkomere. Titin-
Moleküle verbinden die Z-Scheibe mit der M-Linie und haben strukturelle, elastische und 
Signalfunktionen in den Myozyten. Die Primärstrukturermittlung einiger Titinisoformen und 
die mechanische Charakterisierung verschiedener Muskelgewebe zeigten, dass die 
Titinelastizität durch differenzielles Spleißen der Titin-Federregion moduliert wird, indem  
unterschiedlich lange Segmente eingebaut werden bestehend aus Immunglobulin-artigen 
Domänen, einer so genannten PEVK-Region und größeren einzigartigen Sequenzinsertionen 
wie N2-B. Das Molekulargewicht einer Titinisoform korreliert mit seinen 
Federeigenschaften: je kleiner (kürzer) die Isoform, desto steifer die Feder. Die Herzmuskeln 
von Säugern koexprimieren zwei Haupt-Titinisoformen, das steife N2B-Titin und das 
weniger steife N2BA-Titin. Die Sarkomer-Steifigkeit wird durch Einstellung des 
Expressionsverhältnisses von N2BA zu N2B justiert, während die Gesamttitinmenge in 
einem Sarkomer wohl aufgrund stöchiometrischer Restriktionen konstant ist.  
Zielsetzungen der Arbeit: 1) Ermittlung des Titinisoformenexpressionsmusters in 
verschiedenen Muskelgeweben unter Verwendung von hochauflösender Gelelektrophorese 
und Western blot; 2) Aufzeigen der funktionalen Bedeutung der Expression verschiedener 
Herztitinisoformen; 3) Analyse möglicher Veränderungen in der Expression des Herztitins im 
kranken Myokard; 4) Etablierung von Faktoren, die für das Herz-Titinexpressionsmuster 
relevant sind; 5) Verstehen der Konsequenzen der pathologischen Änderungen in der 
Titinexpression für das kranke Herz.  
Methoden und Ergebnisse: Das N2BA:N2B Titinisoformenverhältnis wurde durch 
Elektrophorese unter Verwendung besonders poröser Polyacrylamidgele bestimmt. Das 
Titinisoformenverhältnis war unterschiedlich: 1) in den Herzen von verschiedenen Säugetier- 
Species; 2) in verschiedenen Regionen des gleichen Herzens; und 3) in kranken gegenüber 
normalen menschlichen Herzen. Western Blots unter Verwendung sequenzspezifischer 
Titinantikörper bestätigten die Identität der Titinbanden. Der N2BA-Anteil schwankte von 
~5% im linken Ventrikel der Ratte bis nahezu 70% im rechten Ventrikel der Kuh. Das 
N2BA:N2B Verhältnis war im Allgemeinen im rechten Ventrikel größer als im linken 
Ventrikel und war an der Herzbasis leicht höher als an der Herzspitze ein und desselben 
Herzens (untersucht in Ziege und Kaninchen). Das Titinisoformenmuster war in kranken 
humanen Herzen verändert: in wegen Koronararterienkrankheit (CAD) transplantierten 
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Herzen bestand ein durchschnittliches N2BA:N2B Verhältnis von 47:53, während normale 
Spenderherzen ein Verhältnis von ~30:70 zeigten. Ein erhöhter Expressionsanteil der 
größeren N2BA-Titinisoform wurde auch in den Herzen von Patienten mit Dilatativer 
Kardiomyopathie (DCM) beobachtet.  
Eine Koexpression von N2BA- und N2B-Titin im gleichen Sarkomer wurde mittels 
Immunfluoreszenzmikroskopie gezeigt. Ein regelmäßiges quergestreiftes Färbemuster für 
Titin auf Gewebeabschnitten von CAD-Herzen deutete auf eine uniforme Veränderung der 
Titinexpression hin, nicht aber auf strukturelle Schäden im Titin. Die funktionale Bedeutung 
der beobachteten Titinexpressionsveränderungen wurde in mechanischen Experimenten mit 
isolierten Myofibrillen menschlicher Herzen untersucht. Kranke Myofibrillen (CAD, DCM) 
mit erhöhtem N2BA-Anteil offenbarten eine abgesenkte passive Steifigkeit im Vergleich mit 
Myofibrillen aus normalen Donorherzen. Die Sarkomere konnten also ihre passive Spannung 
ändern, indem sie das N2BA:N2B Expressionsverhältnis modulierten. Insuffiziente humane 
Herzen haben demzufolge, selbst wenn sie global versteift sind (Kollagen hochreguliert), 
schlaffere Myofibrillen als normale menschliche Spenderherzen.  
Eine Titinisoformenveränderung wurde auch an einem Rattemodell mit 
experimentellem Myokardinfarkt nach LAD-Ligatur untersucht. Titingele zeigten, dass 43% 
der kranken Herzen eine eindeutige N2BA-Bande aufwiesen, während nur 14% der Herzen 
Sham-operierter Tiere eine N2BA-Bande zeigten. Die Befunde demonstrierten, dass in 
diesem Tiermodell eine Titin-Isoformenveränderung hin zu N2BA induzierbar war.  
Schlussfolgerungen: Eine verbesserte Titinisoformendetektion durch Verwendung 
niedrigprozentiger (2%) SDS-Polyacrylamid-Gele offenbarte das Vorhandensein vieler 
verschieden großer Titinisoformen in unterschiedlichen Muskelgeweben. Die Arbeit 
dokumentiert die elastische Vielfalt des Titins sowie deren Veränderungen bei menschlichen 
Herzerkrankungen und in der Entwicklung. Die Veränderung hin zu schlaffen N2BA-
Isoformen im terminal insuffizienten humanen Herzen beeinflusst die mechanischen 
Eigenschaften der Kardiomyozyten, insbesondere deren passive Steifigkeit. Die 
krankheitsbedingte Verschiebung im Titinisoformenverhältnis könnte auch die Kontraktilität 
verschlechtern, indem z.B. die Fähigkeit des Herzens, den Frank-Starling-Mechanismus zu 
verwenden, behindert wird. 
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